<!DOCTYPE html>
<html lang="en" prefix="dc: http://purl.org/dc/elements/1.1/#; dcterms: http://purl.org/dc/terms/#">
<head><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta charset="utf-8"><meta name="viewport" content="width=device-width"><script type="text/javascript" src="../../../wicket/resource/org.apache.wicket.resource.JQueryResourceReference/jquery/jquery-1.11.1.min-ver-8101D596B2B8FA35FE3A634EA342D7C3.js"></script>
<link rel="stylesheet" type="text/css" href="/css_min/min/orcid-min.css?v=12087" />
<script type="text/javascript" src="../../../wicket/resource/org.europepmc.account.AccountSigninPanel/AccoutSigninPanel-ver-23536C62407C81CFCDCB80EBF689D4C9.js"></script>
<title>Europe PMC</title><link href="/css/chunk-00f8ff4e.a8744ce3.css" rel="prefetch"><link href="/css/chunk-0174ae6e.dbe6b2e6.css" rel="prefetch"><link href="/css/chunk-0e93dfce.dd3b2cb4.css" rel="prefetch"><link href="/css/chunk-295e29ee.f8971f0e.css" rel="prefetch"><link href="/css/chunk-2a369350.d9f0ba2d.css" rel="prefetch"><link href="/css/chunk-35525521.b680659e.css" rel="prefetch"><link href="/css/chunk-47525778.f2f693d5.css" rel="prefetch"><link href="/css/chunk-47c0a591.fe43186a.css" rel="prefetch"><link href="/css/chunk-517b3bcb.09aadcce.css" rel="prefetch"><link href="/css/chunk-5609bc5c.c37ed247.css" rel="prefetch"><link href="/css/chunk-5b9304ba.03921488.css" rel="prefetch"><link href="/css/chunk-65109596.53d94091.css" rel="prefetch"><link href="/css/chunk-6602419f.190a4303.css" rel="prefetch"><link href="/css/chunk-698cb8bb.6207fd84.css" rel="prefetch"><link href="/css/chunk-720193c3.adeb4bbb.css" rel="prefetch"><link href="/css/chunk-745b9968.c78a9010.css" rel="prefetch"><link href="/css/chunk-76f0c490.413cd20e.css" rel="prefetch"><link href="/css/chunk-7724a5fd.3ce2e8da.css" rel="prefetch"><link href="/css/chunk-7c0aaf82.9ba4ea01.css" rel="prefetch"><link href="/css/chunk-7d19ffa5.97a42430.css" rel="prefetch"><link href="/css/chunk-7fc48d7e.c7ea151b.css" rel="prefetch"><link href="/css/chunk-807a2bd6.b85915e5.css" rel="prefetch"><link href="/css/chunk-87669856.c795efbe.css" rel="prefetch"><link href="/css/chunk-89a70d92.cafb0726.css" rel="prefetch"><link href="/css/chunk-8bb8901a.61d525d8.css" rel="prefetch"><link href="/css/chunk-b547d4f6.ca89be19.css" rel="prefetch"><link href="/css/chunk-b744e2c0.e8f4ac41.css" rel="prefetch"><link href="/css/chunk-cac315d4.47cc104a.css" rel="prefetch"><link href="/css/chunk-d361715e.660f509f.css" rel="prefetch"><link href="/css/chunk-d5615dc8.ded582d7.css" rel="prefetch"><link href="/css/chunk-dc875800.aef99452.css" rel="prefetch"><link href="/css/chunk-e9e7d366.c4482499.css" rel="prefetch"><link href="/css/chunk-vendors.a2fcebda.css" rel="stylesheet"><link href="/css/app.4c380042.css" rel="stylesheet"><title>Europe PMC</title><script src="https://cdn.jsdelivr.net/npm/get-root-node-polyfill@1.0.0/index.min.js"></script><script id="uk-bl-ukpmc-web-pages-template-SearchBar-0">
/*<![CDATA[*/
// for processing latex encoding in abstract and fulltext
window.MathJax = {
tex: {
inlineMath: [['$', '$'], ['\\(', '\\)']]
}
};
/*]]>*/
</script><link href="/css/chunk-00f8ff4e.a8744ce3.css" rel="prefetch"><link href="/css/chunk-0174ae6e.dbe6b2e6.css" rel="prefetch"><link href="/css/chunk-0e93dfce.dd3b2cb4.css" rel="prefetch"><link href="/css/chunk-295e29ee.f8971f0e.css" rel="prefetch"><link href="/css/chunk-2a369350.d9f0ba2d.css" rel="prefetch"><link href="/css/chunk-35525521.b680659e.css" rel="prefetch"><link href="/css/chunk-47525778.f2f693d5.css" rel="prefetch"><link href="/css/chunk-47c0a591.fe43186a.css" rel="prefetch"><link href="/css/chunk-517b3bcb.09aadcce.css" rel="prefetch"><link href="/css/chunk-5609bc5c.c37ed247.css" rel="prefetch"><link href="/css/chunk-5b9304ba.03921488.css" rel="prefetch"><link href="/css/chunk-65109596.53d94091.css" rel="prefetch"><link href="/css/chunk-6602419f.190a4303.css" rel="prefetch"><link href="/css/chunk-698cb8bb.6207fd84.css" rel="prefetch"><link href="/css/chunk-720193c3.adeb4bbb.css" rel="prefetch"><link href="/css/chunk-745b9968.c78a9010.css" rel="prefetch"><link href="/css/chunk-76f0c490.413cd20e.css" rel="prefetch"><link href="/css/chunk-7724a5fd.3ce2e8da.css" rel="prefetch"><link href="/css/chunk-7c0aaf82.9ba4ea01.css" rel="prefetch"><link href="/css/chunk-7d19ffa5.97a42430.css" rel="prefetch"><link href="/css/chunk-7fc48d7e.c7ea151b.css" rel="prefetch"><link href="/css/chunk-807a2bd6.b85915e5.css" rel="prefetch"><link href="/css/chunk-87669856.c795efbe.css" rel="prefetch"><link href="/css/chunk-89a70d92.cafb0726.css" rel="prefetch"><link href="/css/chunk-8bb8901a.61d525d8.css" rel="prefetch"><link href="/css/chunk-b547d4f6.ca89be19.css" rel="prefetch"><link href="/css/chunk-b744e2c0.e8f4ac41.css" rel="prefetch"><link href="/css/chunk-cac315d4.47cc104a.css" rel="prefetch"><link href="/css/chunk-d361715e.660f509f.css" rel="prefetch"><link href="/css/chunk-d5615dc8.ded582d7.css" rel="prefetch"><link href="/css/chunk-dc875800.aef99452.css" rel="prefetch"><link href="/css/chunk-e9e7d366.c4482499.css" rel="prefetch"><link href="/js/chunk-00f8ff4e.af74e61a.js" rel="prefetch"><link href="/js/chunk-0174ae6e.d3cacd5f.js" rel="prefetch"><link href="/js/chunk-0e93dfce.321ffb80.js" rel="prefetch"><link href="/js/chunk-295e29ee.b8a472ef.js" rel="prefetch"><link href="/js/chunk-2a369350.2147e680.js" rel="prefetch"><link href="/js/chunk-2d0b33fc.609beb49.js" rel="prefetch"><link href="/js/chunk-2d0bad09.f6760def.js" rel="prefetch"><link href="/js/chunk-2d0c95e3.58c43335.js" rel="prefetch"><link href="/js/chunk-2d0de79d.a0c7b2e2.js" rel="prefetch"><link href="/js/chunk-2d0f07fe.3dc34507.js" rel="prefetch"><link href="/js/chunk-2d213782.2843e639.js" rel="prefetch"><link href="/js/chunk-35525521.7a6c2492.js" rel="prefetch"><link href="/js/chunk-47525778.a6002a62.js" rel="prefetch"><link href="/js/chunk-47c0a591.17630c5f.js" rel="prefetch"><link href="/js/chunk-517b3bcb.184d8521.js" rel="prefetch"><link href="/js/chunk-5609bc5c.d37b3a7b.js" rel="prefetch"><link href="/js/chunk-5b9304ba.c9710dd0.js" rel="prefetch"><link href="/js/chunk-65109596.fbd51649.js" rel="prefetch"><link href="/js/chunk-6602419f.12a79d33.js" rel="prefetch"><link href="/js/chunk-698cb8bb.31b79321.js" rel="prefetch"><link href="/js/chunk-720193c3.62a49fed.js" rel="prefetch"><link href="/js/chunk-745b9968.42a25d50.js" rel="prefetch"><link href="/js/chunk-76f0c490.3ef2dfd5.js" rel="prefetch"><link href="/js/chunk-7724a5fd.265f2917.js" rel="prefetch"><link href="/js/chunk-7c0aaf82.b478f2ef.js" rel="prefetch"><link href="/js/chunk-7d19ffa5.56bb5fe0.js" rel="prefetch"><link href="/js/chunk-7fc48d7e.cef9ed0a.js" rel="prefetch"><link href="/js/chunk-807a2bd6.5d551d17.js" rel="prefetch"><link href="/js/chunk-87669856.b9a1d797.js" rel="prefetch"><link href="/js/chunk-89a70d92.f98062d6.js" rel="prefetch"><link href="/js/chunk-8bb8901a.2dd60e6f.js" rel="prefetch"><link href="/js/chunk-b547d4f6.959b9c11.js" rel="prefetch"><link href="/js/chunk-b744e2c0.45d10e41.js" rel="prefetch"><link href="/js/chunk-cac315d4.5b23dd5c.js" rel="prefetch"><link href="/js/chunk-d361715e.e7929841.js" rel="prefetch"><link href="/js/chunk-d5615dc8.573ba8a8.js" rel="prefetch"><link href="/js/chunk-dc875800.c81ff22b.js" rel="prefetch"><link href="/js/chunk-e9e7d366.6b143670.js" rel="prefetch"><link href="/css/app.4c380042.css" rel="preload" as="style"><link href="/css/chunk-vendors.a2fcebda.css" rel="preload" as="style"><link href="/js/app.81624b29.js" rel="preload" as="script"><link href="/js/chunk-vendors.22a07bda.js" rel="preload" as="script"><link href="/css/chunk-vendors.a2fcebda.css" rel="stylesheet"><link href="/css/app.4c380042.css" rel="stylesheet"><script type="text/javascript" src="../../../wicket/resource/org.apache.wicket.ajax.AbstractDefaultAjaxBehavior/res/js/wicket-event-jquery.min-ver-F070EDFAD7E5A1BD9662F385470094FF.js"></script>
<script type="text/javascript" src="../../../wicket/resource/org.apache.wicket.ajax.AbstractDefaultAjaxBehavior/res/js/wicket-ajax-jquery.min-ver-1D4EE56166B3A1106E05B678CC2AB1EF.js"></script>
<script type="text/javascript" src="../../../wicket/resource/org.apache.wicket.extensions.ajax.markup.html.modal.ModalWindow/res/modal.min-ver-E43C9229F7812A6259B89C7E5B5028FB.js"></script>
<link rel="stylesheet" type="text/css" href="../../../wicket/resource/org.apache.wicket.extensions.ajax.markup.html.modal.ModalWindow/res/modal.min-ver-E99D4201F0F6C5D3081AD42ACB1F22C2.css" />
<script type="text/javascript" id="wicket-ajax-base-url">
/*<![CDATA[*/
Wicket.Ajax.baseUrl="articles/pmc4724133/bin/13075_2016_914_moesm5_esm.ods";
/*]]>*/
</script>

<style id="uk-bl-ukpmc-web-pages-template-TemplatePage-0">
/*<![CDATA[*/

#search-feature-link {
display: none;
}
@media only screen and (max-width: 800px) {
#search-feature-link {
display: block;
}
}

/*]]>*/
</style>
<script type="text/javascript" src="../../../wicket/resource/uk.bl.ukpmc.web.pages.template.TemplatePage/TemplatePage-ver-540ECA69167ECC178EB8C919D0809EB3.js"></script>


<meta name="dc:date" content="2016/01"/>

<meta name="dcterms:isPartOf" content="Arthritis Research &amp; Therapy 2016, 18, pp27"/>

<meta name="dc:identifier" content="https://www.ncbi.nlm.nih.gov/pubmed/26801089"/>

<meta name="dc:identifier" content="https://doi.org/10.1186/s13075-016-0914-4"/>

<meta name="dcterms:hasFormat" content="https://doi.org/10.1186/s13075-016-0914-4"/>

<meta name="dc:title" content="Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis."/>

<meta name="dc:Type" content="Research Support, Non-U.S. Gov&#039;t"/>

<meta name="dc:Type" content="research-article"/>

<meta name="dc:Type" content="Research Support, U.S. Gov&#039;t, Non-P.H.S."/>

<meta name="dc:Type" content="Journal Article"/>

<meta name="dc:Type" content="Research Support, N.I.H., Extramural"/>

<meta name="dc:creator" content="Johnson ME"/>

<meta name="dc:creator" content="Grassetti AV"/>

<meta name="dc:creator" content="Taroni JN"/>

<meta name="dc:creator" content="Lyons SM"/>

<meta name="dc:creator" content="Schweppe D"/>

<meta name="dc:creator" content="Gordon JK"/>

<meta name="dc:creator" content="Spiera RF"/>

<meta name="dc:creator" content="Lafyatis R"/>

<meta name="dc:creator" content="Anderson PJ"/>

<meta name="dc:creator" content="Gerber SA"/>

<meta name="dc:creator" content="Whitfield ML"/>

<meta name="dc:contributor" content="Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. michael.e.johnson@dartmouth.edu."/>

<meta name="dc:language" content="en"/>

<meta name="dc:subject" content="info:mesh/Hela Cells"/>

<meta name="dc:subject" content="info:mesh/Humans"/>

<meta name="dc:subject" content="info:mesh/Scleroderma, Systemic"/>

<meta name="dc:subject" content="info:mesh/Autoantibodies"/>

<meta name="dc:subject" content="info:mesh/Autoantigens"/>

<meta name="dc:subject" content="info:mesh/Fluorescent Antibody Technique, Indirect"/>

<meta name="dc:subject" content="info:mesh/RNA Processing, Post-Transcriptional"/>

<meta name="dc:subject" content="info:mesh/Adult"/>

<meta name="dc:subject" content="info:mesh/Aged"/>

<meta name="dc:subject" content="info:mesh/Middle Aged"/>

<meta name="dc:subject" content="info:mesh/Female"/>

<meta name="dc:subject" content="info:mesh/Male"/>

<meta name="dc:subject" content="info:mesh/Young Adult"/>

<meta name="dc:subject" content="info:mesh/Biomarkers"/>



<meta name="citation_journal_title" content="Arthritis research &amp; therapy"/>

<meta name="citation_journal_abbrev" content="Arthritis Res Ther"/>

<meta name="citation_publication_date" content="2016/01"/>

<meta name="citation_issn" content="1478-6354"/>

<meta name="citation_volume" content="18"/>

<meta name="citation_firstpage" content="27"/>

<meta name="citation_lastpage" content="27"/>

<meta name="citation_title" content="Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis."/>

<meta name="citation_doi" content="10.1186/s13075-016-0914-4"/>

<meta name="citation_pmcid" content="PMC4724133"/>

<meta name="citation_author" content="ME Johnson"/>

<meta name="citation_author" content="AV Grassetti"/>

<meta name="citation_author" content="JN Taroni"/>

<meta name="citation_author" content="SM Lyons"/>

<meta name="citation_author" content="D Schweppe"/>

<meta name="citation_author" content="JK Gordon"/>

<meta name="citation_author" content="RF Spiera"/>

<meta name="citation_author" content="R Lafyatis"/>

<meta name="citation_author" content="PJ Anderson"/>

<meta name="citation_author" content="SA Gerber"/>

<meta name="citation_author" content="ML Whitfield"/>

<meta name="citation_keywords" content="Hela Cells; Humans; Scleroderma, Systemic; Autoantibodies; Autoantigens; Fluorescent Antibody Technique, Indirect; RNA Processing, Post-Transcriptional; Adult; Aged; Middle Aged; Female; Male; Young Adult; Biomarkers"/>

<meta name="citation_language" content="eng"/>







<meta name="bioentities" content="panel"/>


<meta name="dcterms:hasFormat" content="http://europepmc.org/articles/pmc4724133"/>

<meta name="citation_fulltext_html_url" content="http://europepmc.org/articles/pmc4724133"/>

<meta name="dc:identifier" content="http://europepmc.org/articles/pmc4724133"/>

<meta name="dcterms:hasFormat" content="http://europepmc.org/abstract/MED/26801089"/>

<meta name="citation_abstract_html_url" content="http://europepmc.org/abstract/MED/26801089"/>

<meta name="dcterms:hasFormat" content="http://europepmc.org/articles/pmc4724133?pdf=render"/>

<meta name="citation_pdf_url" content="http://europepmc.org/articles/pmc4724133?pdf=render"/>

<script type="text/javascript" id="uk-bl-ukpmc-web-panels-navigation-FullTextMarginPanel-0">
/*<![CDATA[*/

$(function () {
topSpace();
});
$(window).resize(function () {
topSpace();
positionLegendAnnotation(true, true, false);
});
function topSpace() {
setTimeout(function () {
if ($('#movetotop').css('position') == 'absolute') {
$('.epmc_wideLeft').css('margin-top', $('#movetotop').height() + 'px');
} else {
$('.epmc_wideLeft').css('margin-top', 0);
}
if ($('.ui-tabs-nav').css('position') == 'absolute') {
$('.ui-tabs').css('padding-bottom', $('.ui-tabs-nav').height() + 10 + 'px');
} else {
$('.ui-tabs').css('padding-bottom', 0);
}
});
}

/*]]>*/
</script>
<style id="uk-bl-ukpmc-web-panels-navigation-FullTextMarginPanel-1">
/*<![CDATA[*/

#downloadHeading {
width:80px; text-align: center; margin-left:5px
}
@media screen and (max-width: 870px) {
#downloadHeading {
display: none !important;
}
#movetotop {
padding: 0rem 2rem !important;
}
.articleContentPage #movetotop .vertmenu:first-child {
margin-top: 10px !important;
}
.articleContentPage.citationPage .epmc_wideLeft {
margin-top: 5.5rem !important;
}
}

/*]]>*/
</style>

<title>Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis - Europe PMC Article - Europe PMC</title>
<link rel="stylesheet" href="/template/font-awesome/css/all.min.css">
<link rel="stylesheet" href="/template/EPMC-iconfont/style.css?v=12087">
<link rel="icon" href="/images/favicon.ico" type="image/x-icon">
<link rel="alternate" type="application/rss+xml"
title="Europe PMC: Popular articles"
href="/Funders/RSS/MostViewedArticles.xml">
<link rel="alternate" type="application/rss+xml"
title="Europe PMC: Recent articles"
href="/Funders/RSS/AllFunders.xml">
<link rel="alternate" type="application/rss+xml"
title="Europe PMC: Latest journals"
href="/Funders/rss/NewJournals.xml">
<link rel="alternate" type="application/rss+xml"
title="Europe PMC: Content Holdings"
href="/contentrss">
<meta name="theme-color" content="#666"/>
<meta name="author" content="Europe PMC"/>
<meta name="owner" content="Europe PMC"/>
<meta name="keywords"
content="Europe PMC, Europe PubMed Central, open access, research articles, journal articles, abstracts, full text, literature search, clinical guidelines, biological patents, life sciences, bioinformatics, biomedical research, citation search, biomedical journals, ORCIDs, text mining, citation networks, REST APIs "/>
<meta name="description" content="FULL TEXT Abstract: &lt;h4&gt;Background&lt;/h4&gt;Autoantibody profiles represent important patient stratification markers in systemic sclerosis (SSc). Here, we performed..."/>
<meta http-equiv="X-UA-Compatible" content="IE=11" />

<link rel="search" type="application/opensearchdescription+xml" title="Search Europe PMC" href="/tools_epmc/opensearch_epmc.xml">
<link rel="stylesheet" type="text/css" media="print, screen" href="/template/jquery_ui.css?v=12087"/>
<link rel="stylesheet" type="text/css" media="screen" href="/template/jquery_menu.css?v=12087"/>
<script type="text/javascript" src="/template/yahoo-min.js?v=12087"></script>
<script type="text/javascript" src="/template/dom-min.js?v=12087"></script>
<script type="text/javascript" src="/template/enrichment.js?v=12087"></script>
<link rel="stylesheet" type="text/css" media="print, screen" href="/template/enrichment.css?v=12087"/>
<script type="text/javascript" src="/template/hoverIntent.js?v=12087"></script>
<script type="text/javascript" src="/template/jquery.js?v=12087"></script>
<link rel="stylesheet" type="text/css" href="/template/ncbi/epmc.ncbi.css?v=12087"/>
<script type="text/javascript" src="/template/epmc.js?v=12087"></script>
<link rel="stylesheet" type="text/css" href="/template/epmc_new.css?v=12087"/>
<link href="/css/compromise.css" rel="stylesheet" type="text/css"/>

<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://europepmc.org/articles/PMC4724133/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Arthritis Research &#x00026; Therapy" /><meta name="citation_title" content="Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis" /><meta name="citation_date" content="2016" /><meta name="citation_volume" content="18" /><meta name="citation_doi" content="10.1186/s13075-016-0914-4" /><meta name="citation_abstract_html_url" content="/articles/PMC4724133/?report=abstract" /><meta name="citation_pmid" content="26801089" /><meta name="DC.Title" content="Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BioMed Central" /><meta name="DC.Contributor" content="Michael E. Johnson" /><meta name="DC.Contributor" content="Andrew V. Grassetti" /><meta name="DC.Contributor" content="Jaclyn N. Taroni" /><meta name="DC.Contributor" content="Shawn M. Lyons" /><meta name="DC.Contributor" content="Devin Schweppe" /><meta name="DC.Contributor" content="Jessica K. Gordon" /><meta name="DC.Contributor" content="Robert F. Spiera" /><meta name="DC.Contributor" content="Robert Lafyatis" /><meta name="DC.Contributor" content="Paul J. Anderson" /><meta name="DC.Contributor" content="Scott A. Gerber" /><meta name="DC.Contributor" content="Michael L. Whitfield" /><meta name="DC.Date" content="2016" /><meta name="DC.Identifier" content="10.1186/s13075-016-0914-4" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis" /><meta property="og:type" content="article" /><meta property="og:description" content="Autoantibody profiles represent important patient stratification markers in systemic sclerosis (SSc). Here, we performed serum-immunoprecipitations with patient antibodies followed by mass spectrometry (LC-MS/MS) to obtain an unbiased view of all possible ..." /><meta property="og:url" content="https://europepmc.org/articles/PMC4724133/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/ncbi.min.css" type="text/css" data-apply="standalone" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript">if (true || typeof jQuery === "undefined") document.write('[script type="text/javascript" src="/corehtml/pmc/jig/1.14.8/js/jig.min.js"][/script]'.replace(/\[/g,String.fromCharCode(60)).replace(/\]/g,String.fromCharCode(62)));</script><script type="text/javascript">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/MathJax-2.6-latest/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-arthresther.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>


<script type="text/javascript">
/*<![CDATA[*/

$(document).ready(function () {
if (window.location.pathname === '/') {
$(".page_proper").first().addClass('epmc-home-page');
}
$("#Highlight_head").click(function (event) {
event.preventDefault();
$("#Highlight_body").slideToggle();
});
$("#Highlight_body a").click(function (event) {
event.preventDefault();
$("#Highlight_body").slideUp();
});
var locationHost = $.cookie('location_host');
if (typeof locationHost === 'undefined' || locationHost == null || locationHost == "") {
$.cookie("location_host", window.location.host);
}
});

/*]]>*/
</script>


<script type="text/javascript">
/*<![CDATA[*/

Wicket.Event.subscribe('/ajax/call/complete', function (jqEvent, attributes, jqXHR, errorThrown, textStatus) {
if (jqXHR != null && jqXHR.responseText != null &&
(jqXHR.responseText.match("ShowCitationDetails]]></redirect></ajax-response>")
|| jqXHR.responseText.match("articles]]></redirect></ajax-response>"))) {
var ua = window.navigator.userAgent;
var msie = ua.indexOf("MSIE ");
var trident = ua.indexOf("Trident/");
if (msie > 0 || trident > 0) {
window.document.execCommand("Stop");
} else {
window.stop();
}
}
});

/*]]>*/
</script>


<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.0.4/fuse.min.js"></script>
<script type="text/javascript" src="/bioJs/js/sbd_tokenizer.js"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.js"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.Protein3D.js"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.Protein3DCanvas.js"></script>
<script type="text/javascript" src="/bioJs/dependencies/jsmol-14.29.10/jsmol/JSmol.min.nojq.js"></script>
<script type="text/javascript" src="/bioJs/dependencies/jsmol-14.29.10/jsmol/js/Jmol2.js"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorBase.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorAction.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/AnnotatorSharedData.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorGeneRef.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorGreco.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorEvent.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorOpenTarget.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorDisgenet.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorNCBI.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorIntact.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorPheneBank.js?v=12087"></script>
<script type="text/javascript" src="/bioJs/js/Biojs.AnnotatorOger.js?v=12087"></script>
<link rel="stylesheet" type="text/css" src="/bioJs/css/biojs.Protein3D.css" />

<link rel="stylesheet" href="../../../wicket/resource/uk.bl.ukpmc.web.pages.search.ShowText/ShowText-ver-EB8803B44F0A895378D6A75F261C7525.css">
<script src="/Scripts/loglevel.min.js"></script>
<script type="text/javascript" src="/Scripts/snippet_storage.js?v=12087"></script>
<script type="text/javascript" src="../../../wicket/resource/com.googlecode.wicket.jquery.core.resource.JQueryUIResourceReference/jquery-ui.min-ver-80CBC031ED1AE0BD82C578DD2D6A4EA0.js"></script>
<script type="text/javascript" src="/js_min/min/epmc-min.js?v=12087"></script>
<script type="text/javascript" src="/js_min/min/responsify-analytics-min.js?v=12087"></script>
<script type="text/javascript" src="/js_min/min/annotation_highlight-min.js?v=12087"></script>
<script type="text/javascript" src="/js_min/min/biojs_functions-min.js?v=12087"></script>
<link rel="stylesheet" type="text/css" href="/css_min/min/jquery-ui-min.css?v=12087" />
<link rel="stylesheet" type="text/css" href="/css_min/min/advanced_search-min.css?v=12087" />
<link rel="stylesheet" type="text/css" href="/css_min/min/labs_links-min.css?v=12087" />
<link rel="stylesheet" type="text/css" href="/css_min/min/annotation_highlight-min.css?v=12087" />
<script type="text/javascript" >
/*<![CDATA[*/
Wicket.Event.add(window, "domready", function(event) { 
Wicket.Ajax.ajax({"c":"id1","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-search-recentsearches","e":"click"});;
Wicket.Ajax.ajax({"c":"id2","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-search-clipboard","e":"click"});;
Wicket.Ajax.ajax({"c":"exportPanelLink","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-search-exportPanelLink","e":"click","coh":[function(attrs, jqXHR, textStatus){;onClickPanelLink();registerExportPanel();}]});;
Wicket.Ajax.ajax({"c":"closeExportWindow","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-search-closeExportWindow","e":"click"});;
Wicket.Ajax.ajax({"c":"id3","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-clipboard_icon-addclipboard","e":"click"});;
Wicket.Ajax.ajax({"pre":[function(attrs){if (jQuery('#references_loading_label').length ==0){

 return false;

}else{

 return true;

}}],"c":"relatedcitation_link","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_citations","e":"click","bh":[function(attrs){if ((jQuery('#annotation_legend_container') !=undefined) && (jQuery('#annotation_legend_container').length >0)){

 jQuery('#annotation_legend_container').hide();

}}]});;
Wicket.Ajax.ajax({"pre":[function(attrs){if (jQuery('#rel_articles_loading_label').length ==0){

 return false;

}else{

 return true;

}}],"c":"relatedarts_link","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_articles","e":"click","bh":[function(attrs){if ((jQuery('#annotation_legend_container') !=undefined) && (jQuery('#annotation_legend_container').length >0)){

 jQuery('#annotation_legend_container').hide();

}}]});;
Wicket.Ajax.ajax({"pre":[function(attrs){return false;}],"c":"datacites_link","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_dataLinks","e":"click"});;
Wicket.Ajax.ajax({"pre":[function(attrs){if (jQuery('#loading_bioentities_label').length ==0){

 return false;

}else{

 return true;

}}],"c":"relatedentity_link","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_bioentities","e":"click","bh":[function(attrs){if ((jQuery('#annotation_legend_container') !=undefined) && (jQuery('#annotation_legend_container').length >0)){

 jQuery('#annotation_legend_container').hide();

}}]});;
Wicket.Ajax.ajax({"pre":[function(attrs){if (jQuery('#loading_links_label').length ==0){

 return false;

}else{

 return true;

}}],"c":"relatedlabLinks_link","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_labLinks","e":"click","bh":[function(attrs){if ((jQuery('#annotation_legend_container') !=undefined) && (jQuery('#annotation_legend_container').length >0)){

 jQuery('#annotation_legend_container').hide();

}}]});;
Wicket.Ajax.ajax({"c":"id4","u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-yearlyCitationGraph"});;
Wicket.Ajax.ajax({"pre":[function(attrs){if (jQuery('#fragment-related-labLinks').css('display') =='block'){

 return true;

}else{

 return false;

}}],"u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_labLinks","sh":[function(attrs, jqXHR, data, textStatus){if (jQuery('#citationDetails').length>0){

 jQuery('#citationDetails').removeClass('ui-tabs-active');

}

if (jQuery('#fulltext').length>0){

 jQuery('#fulltext').removeClass('ui-tabs-active');

}

}]});;
Wicket.Ajax.ajax({"pre":[function(attrs){if (jQuery('#fragment-related-pubmedarts').css('display') =='block'){

 return true;

}else{

 return false;

}}],"u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_articles","sh":[function(attrs, jqXHR, data, textStatus){if (jQuery('#citationDetails').length>0){

 jQuery('#citationDetails').removeClass('ui-tabs-active');

}

if (jQuery('#fulltext').length>0){

 jQuery('#fulltext').removeClass('ui-tabs-active');

}

}]});;
Wicket.Ajax.ajax({"pre":[function(attrs){if (jQuery('#fragment-related-citations').css('display') =='block'){

 return true;

}else{

 return false;

}}],"u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_citations","sh":[function(attrs, jqXHR, data, textStatus){if (jQuery('#citationDetails').length>0){

 jQuery('#citationDetails').removeClass('ui-tabs-active');

}

if (jQuery('#fulltext').length>0){

 jQuery('#fulltext').removeClass('ui-tabs-active');

}

}]});;
Wicket.Ajax.ajax({"pre":[function(attrs){if (jQuery('#fragment-related-bioentities').css('display') =='block'){

 return true;

}else{

 return false;

}}],"u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_bioentities","sh":[function(attrs, jqXHR, data, textStatus){if (jQuery('#citationDetails').length>0){

 jQuery('#citationDetails').removeClass('ui-tabs-active');

}

if (jQuery('#fulltext').length>0){

 jQuery('#fulltext').removeClass('ui-tabs-active');

}

}]});;
Wicket.Ajax.ajax({"pre":[function(attrs){if (jQuery('#fragment-related-dataLinks').css('display') =='block'){

 return true;

}else{

 return false;

}}],"u":"./13075_2016_914_moesm5_esm.ods?0-1.IBehaviorListener.0-anchor_related_dataLinks","sh":[function(attrs, jqXHR, data, textStatus){if (jQuery('#citationDetails').length>0){

 jQuery('#citationDetails').removeClass('ui-tabs-active');

}

if (jQuery('#fulltext').length>0){

 jQuery('#fulltext').removeClass('ui-tabs-active');

}

}]});;
;});
/*]]>*/
</script>
</head>
<body>
<span style="display:none" id="piwikIdSite">1</span>
<div class="page_proper" id="body">
<noscript>
<div style="text-align:center">
<p><b>Europe PMC</b> requires Javascript to function effectively.</p>
<p>Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please
turn on Javascript support in your web browser and reload this page.</p>
</div>
</noscript>
<header>
<div id="epmc_pageHeader">


<div class="dark-gray">
<div class="container">
<div>
<span>

<span id="id5">
<span style="color: white !important;">
<i class="fa fa-user profile-icon"></i><a id="login-bar--signin-link" class="orcid_signin_text" href="/accounts/login">Sign in</a> | <a class="orcid_signin_text" href="/accounts/registration">Create an account</a>
</span>
</span>
</span>
<iframe id="iframeId" name="aframe" style="border:none" seamless></iframe>
<span id="orcidurlId" class="screenReader">https://orcid.org</span>
<span style="display:none" id="plusLogoutUrl">https://plus.europepmc.org</span>
</div>
</div>
</div>
<nav class="container">
<ul id="epmc_mainNav">
<li>
<div class="logo">
<a href="/" target="_top" accesskey="U">
<span class="screenReader">Europe PMC</span>
</a>
</div>
<a id="menu_button" href="#" onclick="return navDrop(this);" class="">
<span>Menu</span>
</a>
<ul class="dropdown">
<li>
<a href="../../../About" onclick="return navDrop(this);">
<span>About</span>
</a>
<ul class="sub_menu">
<li class="citation_navigation_unselected">
<a href="../../../About">
<span>About Europe PMC</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../Preprints">
<span>Preprints in Europe PMC</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../Funders">
<span>Funders</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../Joining">
<span>Joining Europe PMC</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../Governance">
<span>Governance</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../Roadmap">
<span>Roadmap</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../Outreach">
<span>Outreach</span>
</a>
</li>
</ul>
</li><li>
<a href="../../../tools" onclick="return navDrop(this);">
<span>Tools</span>
</a>
<ul class="sub_menu">
<li class="citation_navigation_unselected">
<a href="../../../tools">
<span>Tools overview</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../ArticleStatusMonitor">
<span>Article status monitor</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../orcid/import">
<span>ORCID article claiming</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../journalList">
<span>Journal list</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../grantfinder">
<span>Grant finder</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../LabsLink">
<span>External links service</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../RssFeeds">
<span>RSS feeds</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../Annotations">
<span>Annotations</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../AnnotationsSubmission">
<span>Annotations submission service</span>
</a>
</li>
</ul>
</li><li>
<a href="../../../developers" onclick="return navDrop(this);">
<span>Developers</span>
</a>
<ul class="sub_menu">
<li class="citation_navigation_unselected">
<a href="../../../developers">
<span>Developer resources</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../RestfulWebService">
<span>Articles RESTful API</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../GristAPI">
<span>Grants RESTful API</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../API-case-studies">
<span>API case studies</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../SoapWebServices">
<span>SOAP web service</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../AnnotationsApi">
<span>Annotations API</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../OaiService">
<span>OAI service</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../downloads">
<span>Bulk downloads</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="http://groups.google.com/a/ebi.ac.uk/forum/#!forum/epmc-webservices">
<span>Developers Forum</span>
</a>
</li>
</ul>
</li><li>
<a href="../../../Help" onclick="return navDrop(this);">
<span>Help</span>
</a>
<ul class="sub_menu">
<li class="citation_navigation_unselected">
<a href="../../../Help">
<span>Help using Europe PMC</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../searchsyntax">
<span>Search syntax reference</span>
</a>
</li><li class="citation_navigation_unselected">
<a href="../../../ContactUs">
<span>Contact us</span>
</a>
</li>
</ul>
</li><li class="contact-us">
<a href="/ContactUs" onclick="return navDrop(this);">
<span>Contact us</span>
</a>
<ul class="sub_menu">
<li>
<a href="/ContactUs">
<span>Helpdesk</span>
</a>
</li>
<li>
<a href="/feedback?url=" onclick="var w = window.open('/feedback?url='+getReferredUrl(), 'ukpmc_feedback', 'scrollbars=no,location=no,menuBar=yes,resizable=yes,status=no,toolbar=yes,width=1050,height=810'); try {if (w.blur) w.focus();}catch(ignore){}; return false;"><span>Feedback</span></a>
</li>
<li>
<a href="https://twitter.com/EuropePMC_news">
<span>Twitter</span>
</a>
</li>
<li>
<a href="http://blog.europepmc.org">
<span>Blog</span>
</a>
</li>
<li>
<a href="//europepmc.github.io/techblog/">
<span>Tech blog</span>
</a>
</li>
<li>
<a href="//groups.google.com/a/ebi.ac.uk/forum/#!forum/epmc-webservices">
<span>Developer Forum</span>
</a>
</li>
</ul>
</li><li class="last">
<a href="https://plus.europepmc.org/" target="epmcplus" onmouseover="TipAllowed('Submit your manuscripts, manage your grants and publish your research impact using &lt;b&gt;Europe PMC plus&lt;/b&gt;')" onmouseout="UnTipAllowed()">
<span>Europe PMC plus</span>
</a>
</li>
</ul>
<div style="clear:both"></div>
</li>
</ul>
</nav>
</div>
<script type="text/javascript">
/*<![CDATA[*/

function openFeedbackForm() {
var referredURL = window.location.origin + window.location.pathname + encodeURIComponent(window.location.search)
var w = window.open(
window.location.protocol + '//' + window.location.host + '/feedback?url=' + referredURL,
'ukpmc_feedback',
'scrollbars=no,location=no,menuBar=yes,resizable=yes,status=no,toolbar=yes,width=550,height=810'
);
try {
if (w.blur) w.focus();
} catch(ignore){};
return false;
}
function navDrop(link){
if ($('#epmc_pageHeader').width() < 870) {
if ($('.nav_clicked').length > 0){
if ($(link).hasClass('nav_clicked')) {
$(link).removeClass('nav_clicked');
} else {
if ($(link).not('#menu_button')) {
$('.nav_clicked').not('#menu_button').removeClass('nav_clicked');
}
$(link).addClass('nav_clicked');
}
} else {
$(link).addClass('nav_clicked');
}
return false;
} else {
return true;
}
}
$(document).ready(function(){
$('#epmc_mainNav a').each(function(){
if($(this).attr('href').replace(/\./g, '').replace(/\//g, '') == window.location.pathname.replace(/\//g, '')){
$(this).addClass('current');
$(this).closest('ul').closest('li').children('a').addClass('current');
}
if(window.location.pathname.replace(/\//g, '').indexOf($(this).attr('href').replace(/\./g, '').replace(/\//g, ''))!= -1){
$(this).addClass('parent');
$(this).closest('ul').closest('li').children('a').addClass('current');
}
});
if (window.location.pathname.includes('AnnotationsApi')) {
$('#epmc_mainNav .dropdown a[href="./tools"]').removeClass('current');
}
});

/*]]>*/
</script>
</header>
<div id="epmc_pageBody">

<div class="articleContentPage">
<script type="text/javascript" src="/Scripts/recaptcha_ajax.js?v=12087"></script>
<div><div id="app" class="epmc-elements"><div data-v-7fb82372=""><div data-v-7fb82372="" id="search-panel" class=""><div data-v-7fb82372="" class="grid-row"><div data-v-7fb82372="" class="col-16"><h1 data-v-7fb82372=""><label data-v-7fb82372="" for="banner--search-input" class="semi-bold">Search life-sciences literature
<span data-v-7fb82372="" id="article-count" class="regular">(<a data-v-7fb82372="" id="article-count-link" href="/search?query=SRC:*">41,433,338</a>
articles, preprints and more)</span></label></h1><div data-v-7fb82372="" id="search-bar"><form data-v-7fb82372="" id="search-bar-inputs" method="get" action="/search"><input data-v-7fb82372="" id="banner--search-input" name="query" type="text"><button data-v-7fb82372="" id="banner--search-button" type="submit" class="regular"><i data-v-7fb82372="" class="fa fa-search"></i><span data-v-7fb82372="" id="search-btn-text">&nbsp;Search</span></button></form><div data-v-7fb82372=""><a data-v-7fb82372="" id="banner--advanced-search" href="/advancesearch">Advanced search</a></div></div></div></div><button data-v-7fb82372="" id="feedback-btn"><i data-v-7fb82372="" class="fas fa-comments"></i>
Feedback
</button><button data-v-7fb82372="" id="ask-me-later-container" style="display: none;"><i data-v-7fb82372="" class="fas fa-clipboard-list"></i><span data-v-7fb82372="" id="survey-label"> Complete Survey</span><span data-v-7fb82372="" id="mobile-survey-label"> Survey</span></button></div><div data-v-a9155804="" data-v-7fb82372="" id="data-protection-banner"><div data-v-a9155804="" class="grid-row"><div data-v-a9155804="" class="col-16"><div data-v-a9155804="" id="data-protection-banner-left">
This website requires cookies, and the limited processing of your
personal data in order to function. By using the site you are agreeing
to this as outlined in our
<a data-v-a9155804="" href="/PrivacyNoticeForEPMC?type=website">privacy notice</a>
and <a data-v-a9155804="" href="/CookiePolicy">cookie policy</a>.
</div><div data-v-a9155804=""><input data-v-a9155804="" id="data-protection-agree" type="button" value="I agree, dismiss this banner" class="secondary"></div></div></div></div></div><div data-v-7fb82372=""><div data-v-7fb82372="" id="search-panel" class=""><div data-v-7fb82372="" class="grid-row"><div data-v-7fb82372="" class="col-16"><h1 data-v-7fb82372=""><label data-v-7fb82372="" for="banner--search-input" class="semi-bold">Search life-sciences literature
<span data-v-7fb82372="" id="article-count" class="regular">(<a data-v-7fb82372="" id="article-count-link" href="/search?query=SRC:*">41,433,338</a>
articles, preprints and more)</span></label></h1><div data-v-7fb82372="" id="search-bar"><form data-v-7fb82372="" id="search-bar-inputs" method="get" action="/search"><input data-v-7fb82372="" id="banner--search-input" name="query" type="text"><button data-v-7fb82372="" id="banner--search-button" type="submit" class="regular"><i data-v-7fb82372="" class="fa fa-search"></i><span data-v-7fb82372="" id="search-btn-text">&nbsp;Search</span></button></form><div data-v-7fb82372=""><a data-v-7fb82372="" id="banner--advanced-search" href="/advancesearch">Advanced search</a></div></div></div></div><button data-v-7fb82372="" id="feedback-btn"><i data-v-7fb82372="" class="fas fa-comments"></i>
Feedback
</button><button data-v-7fb82372="" id="ask-me-later-container" style="display: none;"><i data-v-7fb82372="" class="fas fa-clipboard-list"></i><span data-v-7fb82372="" id="survey-label"> Complete Survey</span><span data-v-7fb82372="" id="mobile-survey-label"> Survey</span></button></div><div data-v-a9155804="" data-v-7fb82372="" id="data-protection-banner"><div data-v-a9155804="" class="grid-row"><div data-v-a9155804="" class="col-16"><div data-v-a9155804="" id="data-protection-banner-left">
This website requires cookies, and the limited processing of your
personal data in order to function. By using the site you are agreeing
to this as outlined in our
<a data-v-a9155804="" href="/PrivacyNoticeForEPMC?type=website">privacy notice</a>
and <a data-v-a9155804="" href="/CookiePolicy">cookie policy</a>.
</div><div data-v-a9155804=""><input data-v-a9155804="" id="data-protection-agree" type="button" value="I agree, dismiss this banner" class="secondary"></div></div></div></div></div></div><script>
/*<![CDATA[*/
//survey changes
function showSurvey(){
$(window).scroll(function(){
if (!navigator.cookieEnabled) {
console.log("Cookie not enabled.");
return;
}
if ($.cookie('no_impact_survey_session')) {
console.log("no_impact_survey_session set.");
return;
}
if ($.cookie('no_impact_survey_app')) {
console.log("no_impact_survey_app set.");
return;
}
$("div#europepmc_impact_survey").show();
});
}
function hideSurvey() {
$("div#europepmc_impact_survey").hide();
$('#ask-me-later-container').hide();
}
function registerGdprAgreeClick() {
var gdprAgreeIntervalId = setInterval(function() {
var gdprBannerDisplay = $('#data-protection-banner').css('display');
if (!gdprBannerDisplay || gdprBannerDisplay === 'none') {
console.log('No GDPR banner...')
showSurvey();
clearInterval(gdprAgreeIntervalId);
return;
}
console.log('GDPR Interval...')
var agreeLink = $("#data-protection-agree");
if (agreeLink) {
$("#data-protection-agree").click(function(){
showSurvey();
});
console.log('GDPR Interval stop')
clearInterval(gdprAgreeIntervalId)
}
}, 100);
}
function repopupSurvey() {
setTimeout(function(){
console.log("no_impact_survey_session set. timeout.");
if ($.cookie('no_impact_survey_app')) {
return;
}
if ($.cookie('no_impact_survey_session')) {
$("div#europepmc_impact_survey").show();
$('#ask-me-later-container').hide();
$.cookie('no_impact_survey_session', null);
}
}, 1800000);
}
function askMeLater() {
$.cookie('no_impact_survey_session', 1);
hideSurvey();
$('#ask-me-later-container').show();
repopupSurvey();
}
function donnotShowMeAgain() {
$.cookie('no_impact_survey_app', 1, {expires : 365});
hideSurvey();
}
$(document).ready(function(){
console.log("inside document ready");
$("div#impact_survey_close").click(function(){
askMeLater();
});
$("#europepmc_impact_survey button").bind("click", function(){
donnotShowMeAgain();
});
$("#ask-me-later-container").bind("click", function(){
donnotShowMeAgain();
$.cookie('no_impact_survey_session', null, {path : '/'});
});
$("a#impact_askMeLater").click(function(){
askMeLater();
});
$("a#impact_donnotShowMeAgain").click(function(){
donnotShowMeAgain();
});
if ($.cookie('no_impact_survey_session')) {
$('#ask-me-later-container').show();
}
registerGdprAgreeClick();
repopupSurvey();
})
// can be removed when moving to Vue
window.onload = function () {
if (window.location.pathname !== '/') {
changeLinks(document.querySelectorAll("#epmc_mainNav a"), "./", "/");
changeLinks(document.querySelectorAll(".top-menu--my-account, .top-menu--manage-account"), "./", "/accounts/");
changeLinks(document.querySelectorAll(".top-menu--my-account, .top-menu--manage-account"), "/accounts/accounts/", "/accounts/");
function changeLinks(links, source, target) {
if (links.length) {
var length = links.length;
for(var i=0; i<length; i++) {
var link = links[i];
var href = link.getAttribute("href");
if (href.startsWith(source)) {
link.setAttribute("href", href.replace(source, target));
}
}
}
}
}
if (window.location.href.includes('orcid/auth/autoclose?auth=true')) {
if (window.opener === undefined) {
localStorage.setItem(
'ORCID_AUTH_SUCCEEDED',
urlParams('auth', window.location.href)
)
if (urlParams('iesupport', window.location.href) == null)
createHiddenIframe()
} else {
window.opener.postMessage(
urlParams('auth', window.location.href),
window.location.protocol + '//' + window.location.host
)
window.opener.postMessage(
urlParams('auth', window.location.href),
window.location.protocol + '//' + window.location.host
)
}
window.close()
}
function urlParams(name, url) {
const results = new RegExp('[\?&]' + name + '=([^&#]*)').exec(url)
return results === null ? null : decodeURI(results[1]) || 0
}
function createHiddenIframe() {
const iframe = document.createElement('iframe')
const url = window.location.href + '&iesupport=true'
iframe.setAttribute('id', 'orcid-auth-redirect')
iframe.style.display = 'none'
iframe.style.border = 'none'
iframe.width = 0
iframe.height = 0
iframe.src =
url.indexOf('https:') !== -1
? url.replace('https:', 'http:')
: url.replace('http:', 'https:')
document.body.appendChild(iframe)
}
}
/*]]>*/
</script><script src="/js/chunk-vendors.22a07bda.js"></script><script src="/js/app.81624b29.js"></script></div>

<div class="container">
<div id="searchToolsBox">
<div id="searchTools" style="display:none">
<div class="epmc_searchTools">


<a href="./13075_2016_914_moesm5_esm.ods?0-1.ILinkListener-search-recentsearches" class="ukpmc_toolbar" onmouseover="TipAllowed(&#039;View your Recent Activity summary.&#039;, DELAY, 1000)" onmouseout="UnTipAllowed()" id="id1">
<i class="fas fa-clock"></i>
Recent Activity
</a>
<div id="id6" style="display:none">
<div id="id7" style="display:none"></div>
</div>
<a style="display:none" href="#" class="ukpmc_toolbar"
onmouseover="TipAllowed('View your Export List summary', DELAY, 1000)" onmouseout="UnTipAllowed()">
<i class="fa fa-download"></i>Export List
</a>
<a style="display:none" href="./13075_2016_914_moesm5_esm.ods?0-1.ILinkListener-search-clipboard" class="ukpmc_toolbar" onmouseover="TipAllowed(&#039;View your Clipboard summary.&lt;br/&gt;This is a temporary store for items of interest to you.&lt;br/&gt;The items may be cleared after 24 hours.&#039;, DELAY, 1000)" onmouseout="UnTipAllowed()" id="id2">
<i class="fa fa-download"></i>
Clipboard
</a>
<div id="id8" style="display:none">
<div id="id9" style="display:none"></div>
</div>
<a id="exportPanelLink" href="javascript:;" class="ukpmc_toolbar" onmouseover="TipAllowed(&#039;Export citations&#039;, DELAY, 1000)" onmouseout="UnTipAllowed()">
<i class="fa fa-download"></i>Export
</a>

<div class="social_network_buttons">
<span id="twitter_article_button" class="social_network_button"><a href="https://twitter.com/share" onmouseover="TipAllowed('Tweet the article')" onmouseout="UnTipAllowed()" class="twitter-share-button"  data-size="medium" data-count="none" data-text="Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis" data-url=""  data-hashtags="EuropePMC"></a><script type='text/javascript'>!function (d, s, id) {
	var js, fjs = d.getElementsByTagName(s)[0], p = /^http:/.test(d.location) ? 'http' : 'https';
	if (!d.getElementById(id)) {
		js = d.createElement(s);
		js.id = id;
		js.src = p + '://platform.twitter.com/widgets.js';
		js.defer = 'defer';
		fjs.parentNode.insertBefore(js, fjs);

		// @see http://stackoverflow.com/a/14644704/978320
		if(js.readyState) {  //IE
			js.onreadystatechange = function() {
				if ( js.readyState === 'loaded' || js.readyState === 'complete' ) {
					js.onreadystatechange = null;
					twttr.widgets.load();
				}
			};
		} else {  //Others
			js.onload = function() {
				twttr.widgets.load();
			};
		}
	}
}(document, 'script', 'twitter-wjs');
</script></span>
</div>
</div>
</div>
</div>
<div id="exportPanel"></div>
<span id="closeExportWindow"></span>
</div>
<div id="ida">

</div>
<style>
/*<![CDATA[*/

.covid-19-find-out-more {
float: right;
margin-top: 32px;
}
@media screen and (max-width: 1000px) {
.covid-19-find-out-more {
float: none;
margin-top: 16px;
}
}

/*]]>*/
</style>
<script type="text/javascript">
/*<![CDATA[*/

jQuery('#banner--search-input').on('input', function () {
if (jQuery(this).val().length >= 1500) {
alert('The maximum allowed query length is 1500 characters');
}
});
$('#searchButton').on('click', function () {
PiwikAnalyticsTracker.track('Search', 'Keyword', 'Manual Input - ' + $('#textfield').val());
});
function onClickPanelLink() {
var speed = 500;
if ($('#exportPanel').css('display') == 'none') {
$("#exportPanel").slideDown(speed);
$('body').append('<div class="wicket-mask-dark export" style="z-index: 2; position: absolute; top: 0px; left: 0px; background-image: none;"></div>"');
exportDisplaySection();
// $(".results_pagination_range").fadeOut(speed - 100)
$('#exportPanel').focus();
} else {
$("#exportPanel").slideUp(speed);
setTimeout(function () {
$(".wicket-mask-dark.export").remove();
}, speed);
// $(".results_pagination_range").fadeIn(speed + 150);
}
}
$(document).ready(function() {
$('#covid-search-example-link').click(function() {
PiwikAnalyticsTracker.track("Search", "Covid-19", "Clicked Covid search link");
});
$('#covid-19-find-out-more-link').click(function() {
PiwikAnalyticsTracker.track("Home", "Home page", "COVID-19 preprints intiative");
});
})

/*]]>*/
</script>
</div>
<div class="epmc_pageHolder articleContentPage fullPage" itemscope itemtype="http://schema.org/ScholarlyArticle">

<span style="display:none" property="dc:abstract" datatype="xsd:string" itemprop="description">&lt;h4&gt;Background&lt;/h4&gt;Autoantibody profiles represent important patient stratification markers in systemic sclerosis (SSc). Here, we performed serum-immunoprecipitations with patient antibodies followed by mass spectrometry (LC-MS/MS) to obtain an unbiased view of all possible autoantibody targets and their associated molecular complexes recognized by SSc.&lt;h4&gt;Methods&lt;/h4&gt;HeLa whole cell lysates were immunoprecipitated (IP) using sera of patients with SSc clinically positive for autoantibodies against RNA polymerase III (RNAP3), topoisomerase 1 (TOP1), and centromere proteins (CENP). IP eluates were then analyzed by LC-MS/MS to identify novel proteins and complexes targeted in SSc. Target proteins were examined using a functional interaction network to identify major macromolecular complexes, with direct targets validated by IP-Western blots and immunofluorescence.&lt;h4&gt;Results&lt;/h4&gt;A wide range of peptides were detected across patients in each clinical autoantibody group. Each group contained peptides representing a broad spectrum of proteins in large macromolecular complexes, with significant overlap between groups. Network analyses revealed significant enrichment for proteins in RNA processing bodies (PB) and cytosolic stress granules (SG) across all SSc subtypes, which were confirmed by both Western blot and immunofluorescence.&lt;h4&gt;Conclusions&lt;/h4&gt;While strong reactivity was observed against major SSc autoantigens, such as RNAP3 and TOP1, there was overlap between groups with widespread reactivity seen against multiple proteins. Identification of PB and SG as major targets of the humoral immune response represents a novel SSc autoantigen and suggests a model in which a combination of chronic and acute cellular stresses result in aberrant cell death, leading to autoantibody generation directed against macromolecular nucleic acid-protein complexes.</span>
<meta itemprop="datePublished" content="2016/01"/>

<div class="epmc_wideLeft">




<div class="not_found_notification">
<span><i class="fa fa-exclamation-triangle"></i> The snippet could not be located in the article text. This may be because the snippet appears in a figure legend, contains special characters or spans different sections of the article.</span>
</div>
<div id="container-1">

<div class="epmc_citationName">
<div class="clipboard_icon">
<span>
<a href="./13075_2016_914_moesm5_esm.ods?0-1.ILinkListener-clipboard_icon-addclipboard" class="clipboard" id="id3">
<i id="idb" title="Add Citation to Export list" class="far fa-square"></i>
</a>
</span>
</div><h1 class="title" itemprop="headline">
<span class="abs_citation_title" itemprop="name" datatype="xsd:string" property="dc:title">Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.</span>
</h1>
<div class="abs_nonlink_metadata">(PMID:26801089 PMCID:pmc4724133)</div>
<div property="dc:identifier" class="abs_nonlink_metadata" style="display:none">PMID:26801089 PMCID:pmc4724133</div>
</div>

<div id ="tabs_abstract">
<ul class="ui-tabs-nav">
<li id="fulltext">
<a href="#fragment-fulltext" onClick="jQuery('#annotation_legend_container').show();return true;">
<h2>Full Text
<img src="../../../wicket/resource/uk.bl.ukpmc.web.panels.images.UkpmcFavicon/small_logo-ver-AA65016C2A6B5C01BBEF323E29CF92AD.gif?antiCache=1672934726550" alt="" height="14" width="14" onmouseover="TipAllowed(&#039;The full text of this article is available in Europe PMC&#039;, DELAY, 1000)" onmouseout="UnTipAllowed()"/>
</h2>
</a>
</li>
<li id="relatedCitations" class="ui-tabs-enabled"><a href="#fragment-related-citations" id="relatedcitation_link"><h2>Citations</h2></a>
</li><li id="relatedpubmedarts" class="ui-tabs-enabled"><a href="#fragment-related-pubmedarts" id="relatedarts_link"><h2>Related Articles</h2></a>
</li><li id="dataLinksarts" class="ui-tabs-enabled"><a href="#fragment-related-dataLinks" id="datacites_link"><h2>Data</h2></a>
</li><li id="relatedarts" class="ui-tabs-enabled"><a href="#fragment-related-bioentities" id="relatedentity_link"><h2>BioEntities</h2></a>
</li><li id="labLinksarts" class="ui-tabs-enabled"><a href="#fragment-related-labLinks" id="relatedlabLinks_link"><h2>External Links</h2></a></li> </ul>
<div class="ui-tabs-panel ncbi_container" id="fragment-fulltext">

<div class="pmc-wm pmc-wm-column">
<div style="text-align:left; font-size:smaller">
<div><img src="/corehtml/pmc/pmcgifs/logo-arthresther.png" alt="Logo of arthresther" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://arthritis-research.biomedcentral.com/" target="pmc_ext" ref="reftype=publisher&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
</div>
<div id="article_body" itemprop="articleBody">
<div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Arthritis Res Ther</span>. 2016; 18: 27. </span></div><div><span class="fm-vol-iss-date">Published online 2016 Jan 22. </span>  <span class="doi">doi: <a href="//dx.doi.org/10.1186%2Fs13075-016-0914-4" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/s13075-016-0914-4</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4724133</span></div><div class="fm-citation-pmid">PMID: <a href="http://europepmc.org/abstract/MED/26801089">26801089</a></div></div></div></div><h1 class="content-title">Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Johnson%20ME&quot;" class="affpopup" co-rid="_co_id457443" co-class="co-affbox">Michael E. Johnson</a>,<sup></sup> <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Grassetti%20AV&quot;" class="affpopup" co-rid="_co_id766347" co-class="co-affbox">Andrew V. Grassetti</a>,<sup></sup> <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Taroni%20JN&quot;" class="affpopup" co-rid="_co_id457474" co-class="co-affbox">Jaclyn N. Taroni</a>,<sup></sup> <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Lyons%20SM&quot;" class="affpopup" co-rid="_co_id452743" co-class="co-affbox">Shawn M. Lyons</a>,<sup></sup> <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Schweppe%20D&quot;" class="affpopup" co-rid="_co_id452760" co-class="co-affbox">Devin Schweppe</a>,<sup></sup> <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Gordon%20JK&quot;" class="affpopup" co-rid="_co_id452778" co-class="co-affbox">Jessica K. Gordon</a>,<sup></sup> <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Spiera%20RF&quot;" class="affpopup" co-rid="_co_id768255" co-class="co-affbox">Robert F. Spiera</a>,<sup></sup> <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Lafyatis%20R&quot;" class="affpopup" co-rid="_co_id768272" co-class="co-affbox">Robert Lafyatis</a>,<sup></sup> <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Anderson%20PJ&quot;" class="affpopup" co-rid="_co_id768292" co-class="co-affbox">Paul J. Anderson</a>,<sup></sup> <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Gerber%20SA&quot;" class="affpopup" co-rid="_co_id768313" co-class="co-affbox">Scott A. Gerber</a>,<sup></sup> and  <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Whitfield%20ML&quot;" class="affpopup" co-rid="_co_id768334" co-class="co-affbox">Michael L. Whitfield</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_id457443"><h3 class="no_margin">Michael E. Johnson</h3><p><sup></sup>Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Johnson%20ME&quot;">Michael E. Johnson</a></div></div><div id="_co_id766347"><h3 class="no_margin">Andrew V. Grassetti</h3><p><sup></sup>Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Grassetti%20AV&quot;">Andrew V. Grassetti</a></div></div><div id="_co_id457474"><h3 class="no_margin">Jaclyn N. Taroni</h3><p><sup></sup>Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Taroni%20JN&quot;">Jaclyn N. Taroni</a></div></div><div id="_co_id452743"><h3 class="no_margin">Shawn M. Lyons</h3><p><sup></sup>Division of Rheumatology, Immunology, and Allergy, Brigham and Women&#x02019;s Hospital, Boston, MA USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Lyons%20SM&quot;">Shawn M. Lyons</a></div></div><div id="_co_id452760"><h3 class="no_margin">Devin Schweppe</h3><p><sup></sup>Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Schweppe%20D&quot;">Devin Schweppe</a></div></div><div id="_co_id452778"><h3 class="no_margin">Jessica K. Gordon</h3><p><sup></sup>Department of Rheumatology, Hospital for Special Surgery, New York, NY USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Gordon%20JK&quot;">Jessica K. Gordon</a></div></div><div id="_co_id768255"><h3 class="no_margin">Robert F. Spiera</h3><p><sup></sup>Department of Rheumatology, Hospital for Special Surgery, New York, NY USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Spiera%20RF&quot;">Robert F. Spiera</a></div></div><div id="_co_id768272"><h3 class="no_margin">Robert Lafyatis</h3><p><sup></sup>Boston University School of Medicine, Boston, MA USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Lafyatis%20R&quot;">Robert Lafyatis</a></div></div><div id="_co_id768292"><h3 class="no_margin">Paul J. Anderson</h3><p><sup></sup>Division of Rheumatology, Immunology, and Allergy, Brigham and Women&#x02019;s Hospital, Boston, MA USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Anderson%20PJ&quot;">Paul J. Anderson</a></div></div><div id="_co_id768313"><h3 class="no_margin">Scott A. Gerber</h3><p><sup></sup>Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Gerber%20SA&quot;">Scott A. Gerber</a></div></div><div id="_co_id768334"><h3 class="no_margin">Michael L. Whitfield</h3><p><sup></sup>Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH USA </p><p><sup></sup>Dartmouth Medical School, Hinman Box 7400, Hanover, NH 03755 USA </p><div>Find articles by <a href="http://europepmc.org/search/?scope=fulltext&amp;page=1&amp;query=AUTH:&quot;Whitfield%20ML&quot;">Michael L. Whitfield</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="id463789_ai">Author information</a> <a href="#" class="pmctoggle" rid="id463789_an">Article notes</a> <a href="#" class="pmctoggle" rid="id463789_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="id463789_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup></sup>Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, NH USA </div><div class="fm-affl" lang="en" id="Aff2"><sup></sup>Division of Rheumatology, Immunology, and Allergy, Brigham and Women&#x02019;s Hospital, Boston, MA USA </div><div class="fm-affl" lang="en" id="Aff3"><sup></sup>Department of Rheumatology, Hospital for Special Surgery, New York, NY USA </div><div class="fm-affl" lang="en" id="Aff4"><sup></sup>Boston University School of Medicine, Boston, MA USA </div><div class="fm-affl" lang="en" id="Aff5"><sup></sup>Dartmouth Medical School, Hinman Box 7400, Hanover, NH 03755 USA </div><div><span class="fm-affl">Michael E. Johnson, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htuomtrad@nosnhoj.e.leahcim" class="oemail">ude.htuomtrad@nosnhoj.e.leahcim</a></span>.</div><div><a href="#id463789aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="id463789_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2015 Oct 6; Accepted 2016 Jan 3.</div></div><div class="permissions fm-panel half_rhythm hide" id="id463789_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Johnson et al. 2016</div><div class="license half_rhythm">
<strong>Open Access</strong>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<a href="http://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<a href="http://creativecommons.org/publicdomain/zero/1.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/articles/PMC4724133/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="id783072" class="sec sec-first"><h3 id="id783072title">Background</h3><p id="id783075" class="p p-first-last">Autoantibody profiles represent important patient stratification markers in systemic sclerosis (SSc). Here, we performed serum-immunoprecipitations with patient antibodies followed by mass spectrometry (LC-MS/MS) to obtain an unbiased view of all possible autoantibody targets and their associated molecular complexes recognized by SSc.</p></div><div id="id783080" class="sec"><h3 id="id783080title">Methods</h3><p id="id783084" class="p p-first-last">HeLa whole cell lysates were immunoprecipitated (IP) using sera of patients with SSc clinically positive for autoantibodies against RNA polymerase III (RNAP3), topoisomerase 1 (TOP1), and centromere proteins (CENP). IP eluates were then analyzed by LC-MS/MS to identify novel proteins and complexes targeted in SSc. Target proteins were examined using a functional interaction network to identify major macromolecular complexes, with direct targets validated by IP-Western blots and immunofluorescence.</p></div><div id="id783090" class="sec"><h3 id="id783090title">Results</h3><p id="id783093" class="p p-first-last">A wide range of peptides were detected across patients in each clinical autoantibody group. Each group contained peptides representing a broad spectrum of proteins in large macromolecular complexes, with significant overlap between groups. Network analyses revealed significant enrichment for proteins in RNA processing bodies (PB) and cytosolic stress granules (SG) across all SSc subtypes, which were confirmed by both Western blot and immunofluorescence.</p></div><div id="id783100" class="sec"><h3 id="id783100title">Conclusions</h3><p id="id783103" class="p p-first-last">While strong reactivity was observed against major SSc autoantigens, such as RNAP3 and TOP1, there was overlap between groups with widespread reactivity seen against multiple proteins. Identification of PB and SG as major targets of the humoral immune response represents a novel SSc autoantigen and suggests a model in which a combination of chronic and acute cellular stresses result in aberrant cell death, leading to autoantibody generation directed against macromolecular nucleic acid-protein complexes.</p></div><div id="id783110" class="sec sec-last"><h3 id="id783110title">Electronic supplementary material</h3><p id="id783113" class="p p-first-last">The online version of this article (doi:10.1186/s13075-016-0914-4) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Systemic sclerosis, Scleroderma, Autoantibody, RNA processing bodies, Stress granules</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="id770334" class="p p-first">Systemic sclerosis (SSc) is a rare systemic autoimmune disease of unknown etiology characterized by skin fibrosis, internal organ involvement, vascular abnormalities, and autoantibody production. Patients are broadly classified as having either limited (lSSc) or diffuse (dSSc) disease based primarily upon the extent of skin involvement and autoantibody profiles. While a wide array of autoantibodies have been described for SSc, only a small number of these targets are used for clinical diagnosis and stratification. Autoantibodies targeting RNA polymerase III (RNAP3), topoisomerase 1 (TOP1; commonly referred to as Scl70), and centromere proteins (CENP) represent the three the most common, clinically measured autoantibodies observed in SSc [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>, <a href="#CR2" rid="CR2" class=" bibr popnode">2</a>]. Other autoantibodies, including fibrillarin (U3RNP), Pm/Scl, Ku, U1RNP, U11/U12, and Th/To have also been described [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>, <a href="#CR3" rid="CR3" class=" bibr popnode">3</a>] but are not routinely measured for clinical subtyping.</p><p id="id770378">While the processes underlying autoantibody production in SSc remain poorly understood, the presence of certain autoantibodies is strongly predictive of clinical outcomes [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>&#x02013;<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]. TOP1 and RNAP3 autoantibodies are almost exclusively seen in dSSc, while CENP, Th/To, and U1RNP antibodies are more commonly associated with lSSc [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>, <a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]. U3RNP autoantibodies are not associated with either clinical subset, and are often found in conjunction with other autoantibodies, including both TOP1 and CENP [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]. Certain antibodies, such as TOP1 and U11/12, have been shown to be predictive of poorer overall prognosis, including increased likelihood of pulmonary fibrosis [<a href="#CR4" rid="CR4" class=" bibr popnode">4</a>] and cardiac involvement, while RNAP3 autoantibodies have recently been linked to co-occurrence of SSc with cancer [<a href="#CR5" rid="CR5" class=" bibr popnode">5</a>].</p><p id="id770444" class="p p-last">Despite the importance of autoantibodies in SSc, the vast majority of target identification and phenotypic screening has been performed using methods targeting only a single autoantibody, with little ability to detect novel or low abundance autoantibodies. Furthermore, these methods fail to address the possibility of co-occurrence of multiple autoantibodies within a patient, which may have important clinical implications. Autoantigen microarrays have proven successful for screening large numbers of autoantibodies in parallel, however target identification is limited to those antigens produced and printed on the antigen microarrays [<a href="#CR6" rid="CR6" class=" bibr popnode">6</a>]. To address these limitations, we performed immunoprecipitations (IP) of HeLa whole cell lysates using sera from RNAP3-, CENP-, and TOP1-positive patients, as well as healthy controls, followed by mass spectrometry (LC-MS/MS) to provide an unbiased assessment of all autoantibodies present in these SSc patients. This method provides a better view of the full range of autoantibodies present in SSc, including both novel and established targets, and provides insights into the general processes underlying autoantibody production.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Clinical samples</h3><p id="id770479" class="p p-first-last">Patient serum was obtained from Boston University Medical School, Boston (BUMC), MA, USA and the Hospital for Special Surgery (HSS), New York, NY, USA. All relevant study protocols were approved by the Dartmouth College committee for the protection of human subjects, and the internal review boards of both BUMC and HSS. Informed consent was obtained from all patients prior to sample collection. Patients were diagnosed with either dSSc or limited SSc, as determined using the 1980 American College of Rheumatology classification criteria. Detection of major autoantibody reactivities was performed using standard clinical assays.</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">Human cell lysates</h3><p id="id770492" class="p p-first-last">HeLa cells were cultured in DMEM supplemented with 10&#x000a0;% fetal bovine serum (FBS) (v/v) and 100&#x000a0;IU/mL penicillin-streptomycin. Cells were grown to approximately 80&#x000a0;% confluence, harvested in IP lysis buffer (150&#x000a0;mM NaCl, 50&#x000a0;mM Tris pH&#x000a0;7.5, 1&#x000a0;mM MgCl<sub>2</sub>, 1&#x000a0;mM EDTA, 0.5&#x000a0;% Triton X-100, 2.5&#x000a0;mM &#x003b2;-mercaptoethanol, 1&#x000a0;mM sodium molybdate, 1&#x000a0;mM sodium fluoride, 1&#x000a0;mM sodium tartrate, 1&#x000a0;mM dithiothreitol (DTT), and protease inhibitors (Roche, Indianapolis, IN, USA)), lysed by passage through a pre-chilled high-gauge syringe, and centrifuged for 15&#x000a0;minutes to pellet debris. Lysates were then clarified by incubating for 4&#x000a0;h at 4&#x000a0;&#x000b0;C on a rotating platform. Protein concentrations were quantified using a standard bicinchoninic acid (BCA) protein assay kit (Thermo Scientific, Waltham, MA, USA).</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">Serum immunoprecipitation</h3><p id="id770512" class="p p-first-last">Patient serum was cross-linked to Protein G Dynabeads (Invitrogen, St. Louis, MO, USA) prior to IP. First, 100&#x000a0;&#x003bc;L serum (approximately 1&#x000a0;mg IgG) was added to 50&#x000a0;&#x003bc;L Protein G beads and incubated for 5&#x000a0;h at 4&#x000a0;&#x000b0;C. Samples were then washed in PBS, equilibrated in crosslinking buffer (50&#x000a0;mM HEPES, pH&#x000a0;8.2), and cross-linked to Protein G beads by the addition of 20&#x000a0;mM dimethyl pimelimidate and 300&#x000a0;mM HEPES (DMP) solution for 10&#x000a0;minutes at room temperature (repeated three times). The crosslinking reaction was then terminated by the addition of 50&#x000a0;mM ammonium bicarbonate, and the resulting antibody bead mixture added to 500&#x000a0;&#x003bc;L cell lysate (diluted to 4&#x000a0;mg/mL in IP lysis buffer). Samples were incubated overnight at 4&#x000a0;&#x000b0;C on a rotating platform, washed in cold IP lysis buffer, and eluted in a buffer containing 2&#x000a0;% SDS, 75&#x000a0;mM NaCl, 50&#x000a0;mM Tris pH&#x000a0;8.1, and 20&#x000a0;% glycerol at 65&#x000a0;&#x000b0;C for 5&#x000a0;minutes. Eluates were reduced by the addition of 0.1&#x000a0;M dithiothreitol (DTT) (to a final concentration 5&#x000a0;mM), and incubated at 80&#x000a0;&#x000b0;C for 5&#x000a0;minutes. Samples were then resolved by SDS-PAGE, split into high (&#x0003e;60&#x000a0;kDa) and low (&#x0003c;60&#x000a0;kDa) molecular weight fractions and analyzed by mass spectrometry.</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">Mass spectrometry</h3><p id="id770532" class="p p-first">Proteins contained in Coomassie-stained gel regions were digested overnight with trypsin (1:200&#x000a0;w/v) at 37&#x000a0;&#x000b0;C. Following digestion, peptides were extracted from the gels, dried, and analyzed by nanoscale LC-MS/MS. LC-MS/MS analyses were performed on either LTQ Orbitrap Classic or Orbitrap Fusion LC-MS/MS platforms. LTQ Orbitrap Classic analyses were conducted as described previously [<a href="#CR7" rid="CR7" class=" bibr popnode">7</a>].</p><p id="id770547" class="p p-last">For Orbitrap Fusion analyses, samples were loaded onto an EASY-nLC 1000 Liquid Chromatograph (Thermo Scientific, Waltham, MA, USA) and separated by reverse-phase high pressure liquid chromatography (RP-HPLC) using an approximately 36-cm column with a 100-&#x003bc;M inner diameter packed with 3&#x000a0;&#x003bc;m 120&#x000a0;&#x000c5; C<sub>18</sub> particles (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany). The resultant peptide eluate was directed into an Orbitrap Fusion Tribrid Mass Spectrometer operating in a data-dependent sequencing acquisition mode across a 30-minute reverse-phase gradient (6&#x000a0;% acetonitrile, 0.1&#x000a0;% formic acid to 30&#x000a0;% acetonitrile, 0.1&#x000a0;% formic acid) at 350&#x000a0;nL/min flow rate. The Orbitrap Fusion was operated with an Orbitrap MS1 scan at 120&#x000a0;K resolution, followed by Orbitrap MS2 scans of higher energy collision-induced dissociation (HCD) fragment ions (30&#x000a0;% HCD energy) at 15&#x000a0;K resolution using a maximum cycle type of 2&#x000a0;s, precursor ion dynamic exclusion window of 15&#x000a0;s, +2, +3, and +4 precursor ions selected for LC-MS/MS, and maximum ion injection times of 100&#x000a0;ms (MS1) and 50&#x000a0;ms (MS2). The resulting tandem mass spectra were data-searched using the COMET search engine [<a href="#CR8" rid="CR8" class=" bibr popnode">8</a>] against a <em>Homo sapiens</em> proteome database (source: Uniprot; download date: 2 July 2013) with a precursor ion tolerance of +/- 1&#x000a0;Da [<a href="#CR9" rid="CR9" class=" bibr popnode">9</a>] and a fragment ion tolerance of 0.02 Th. Peptide spectra matches (PSMs) were filtered to &#x0003c;1&#x000a0;% false discovery rate using the target decoy strategy [<a href="#CR10" rid="CR10" class=" bibr popnode">10</a>], and reported.</p></div><div id="Sec7" class="sec"><h3 id="Sec7title">IP-western blots</h3><p id="id778066" class="p p-first-last">Anti-UPF1 antibody was kindly provided by Dr. Lynne Maquat (University of Rochester Medical Center, Rochester, NY, USA). Antibodies to MOV10 and CAPRIN1 were purchased from Proteintech (Chicago, IL, USA); antibodies to G3BP1 and USP10 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Serum immunoprecipitation of HeLa lysates was performed as described above; 50&#x000a0;% of each eluate (15&#x000a0;&#x003bc;L) was then run on a 10&#x000a0;% bis-tris precast gel (Life Technologies, Carlsbad, CA, USA). HeLa whole cell lysate (100&#x000a0;&#x003bc;g) was used as a positive control; no loading control was performed due to the absence of viable targets present in all IP eluates. Western blots were then run following standard protocols, and visualized using Western Lightning ECL Pro or Ultra substrate (Perkin Elmer Inc., Waltham, MA, USA), as necessary.</p></div><div id="Sec8" class="sec"><h3 id="Sec8title">Data analysis</h3><p id="id778082" class="p p-first-last">Non-redundant peptide hits, defined as mass spectra mapping exclusively to a given peptide fragment, were used for all downstream analyses. Pairwise comparisons between samples were performed by Fisher&#x02019;s exact test using the Bonferroni correction for multiple hypothesis testing. Venn diagrams were generated using VENNY [<a href="#CR11" rid="CR11" class=" bibr popnode">11</a>]. Network analysis was performed using the Genome-scale Integrated Analysis of gene Networks in Tissues (GIANT; <a href="http://giant.princeton.edu/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://giant.princeton.edu/</a>) global network [<a href="#CR12" rid="CR12" class=" bibr popnode">12</a>] and visualized using Cytoscape [<a href="#CR13" rid="CR13" class=" bibr popnode">13</a>]. Communities in the network were detected using fast-greedy modularity as implemented in igraph. Functional annotation of individual communities was performed using g:Profiler [<a href="#CR14" rid="CR14" class=" bibr popnode">14</a>]. Semiquantitative enrichment of SSc-associated autoantibodies was determined using a binary assessment of autoantibody presence or absence in a sample. Preferential enrichment in SSc was defined as all proteins detected in &#x0003e;50&#x000a0;% of all patient samples at a frequency &#x0003e;1.5-fold relative to controls. Enrichment of biological processes and cellular components was determined using g:Profiler using the g:SCS threshold correction for multiple hypothesis testing and a functional category size &#x02264;500 genes. Hierarchical clustering was performed using Cluster 3.0 [<a href="#CR15" rid="CR15" class=" bibr popnode">15</a>], and visualized using Java TreeView [<a href="#CR16" rid="CR16" class=" bibr popnode">16</a>].</p></div><div id="Sec9" class="sec sec-last"><h3 id="Sec9title">Immunofluorescence</h3><p id="id778161" class="p p-first-last">The day prior to the experiment, 10<sup>5</sup> U2OS cells were seeded onto 11&#x000a0;mm glass coverslips and allowed to attach overnight at 37&#x000a0;&#x000b0;C/5&#x000a0;% CO<sub>2</sub> in DMEM containing 10&#x000a0;% FBS (Gibco). Cells were treated with 100&#x000a0;&#x003bc;M sodium (meta)arsenite (Sigma Aldrich) for 1&#x000a0;h to induce the formation of stress granules and then with 4&#x000a0;% paraformaldehyde solution at room temperature for 15&#x000a0;minutes followed by blocking and permeabilization with 5&#x000a0;% normal horse serum, 0.1&#x000a0;% digitonin in Tris-buffered saline. Staining was performed with anti-eIF3b (Santa Cruz), anti-SK1-Hedls (Santa Cruz), and patient sera for 1&#x000a0;h at room temperature. Secondary antibodies (anti-goat-Cy3, anti-mouse-Cy2, and anti-human-Cy5) were purchased from Jackson Laboratories and incubated at room temperature for 1&#x000a0;h. Conventional fluorescence microscopy was performed using a microscope (model Elipse E800, Nikon, Tokyo, Japan) with epifluorescence optics with a digital camera (model CCD-SPOT RT; Diagnostic Instruments, Sterling Heights, MI). Images were compiled using Adobe Photoshop software (CS6; Adobe Systems, San Jose, CA).</p></div></div><div id="Sec10" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec10title">Results</h2><div id="Sec11" class="sec sec-first"><h3 id="Sec11title">Identification of proteins cross-reacting to serum antibodies</h3><p id="id778194" class="p p-first">Immunoprecipitations (IP) of HeLa whole cell lysates were performed using sera obtained from 13 SSc patients and 4 healthy controls. HeLa cells were chosen based upon their consistent, high level of expression of a broad range of proteins from the human genome [<a href="#CR17" rid="CR17" class=" bibr popnode">17</a>].</p><p id="id778207" class="p p-last">SSc patients were divided into three groups, TOP1, RNAP3, and CENP, as measured in a reference laboratory; clinical data for each patient are shown in Table&#x000a0;<a href="/articles/PMC4724133/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span>1</span></a>. These groups were chosen based upon their relative frequency, and their importance in clinical diagnosis. Immunoprecipitated proteins were analyzed by LC-MS/MS, and the resulting spectra aligned to the reference human proteome (UCSC version hg19). Data are presented in two ways; first to identify the total number of peptides that could be aligned to each protein (total hits), and second to identify all non-redundant peptides that mapped exclusively to a given protein (non-redundant hits). A complete list of all data can be found in Additional file <a href="#MOESM1" rid="MOESM1" class=" media">1</a>: Table S1.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="id778245">Clinical information for patients involved in this study</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_id778248" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1">Sample</th><th rowspan="1" colspan="1">Group</th><th rowspan="1" colspan="1">Age (years)</th><th rowspan="1" colspan="1">Sex</th><th rowspan="1" colspan="1">Race</th><th rowspan="1" colspan="1">Disease type</th><th rowspan="1" colspan="1">ILD/PAH</th><th rowspan="1" colspan="1">Disease duration (years)</th><th rowspan="1" colspan="1">ANA pattern</th><th rowspan="1" colspan="1">ANA titer</th><th rowspan="1" colspan="1">MRSS</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">SSc 1</td><td rowspan="1" colspan="1">TOP1</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Diffuse</td><td rowspan="1" colspan="1">mild ILD</td><td rowspan="1" colspan="1">2.5</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">1:320</td><td rowspan="1" colspan="1">43</td></tr><tr><td rowspan="1" colspan="1">SSc 132</td><td rowspan="1" colspan="1">TOP1</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Diffuse</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Homogeneous</td><td rowspan="1" colspan="1">1:640</td><td rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">SSc 218</td><td rowspan="1" colspan="1">TOP1</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Diffuse</td><td rowspan="1" colspan="1">ILD</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Homogeneous/nucleolar</td><td rowspan="1" colspan="1">1:2560</td><td rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1">SSc 208</td><td rowspan="1" colspan="1">TOP1</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Diffuse</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Nucleolar</td><td rowspan="1" colspan="1">1:1280</td><td rowspan="1" colspan="1">37</td></tr><tr><td rowspan="1" colspan="1">SSc 5</td><td rowspan="1" colspan="1">RNAP3</td><td rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Diffuse</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">Speckled</td><td rowspan="1" colspan="1">1:80</td><td rowspan="1" colspan="1">36</td></tr><tr><td rowspan="1" colspan="1">SSc 7</td><td rowspan="1" colspan="1">RNAP3</td><td rowspan="1" colspan="1">45</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">Black</td><td rowspan="1" colspan="1">Diffuse</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">0.5</td><td rowspan="1" colspan="1">Speckled</td><td rowspan="1" colspan="1">1:80</td><td rowspan="1" colspan="1">27</td></tr><tr><td rowspan="1" colspan="1">SSc 10</td><td rowspan="1" colspan="1">RNAP3</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Diffuse</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">0.5</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">22</td></tr><tr><td rowspan="1" colspan="1">SSc 18</td><td rowspan="1" colspan="1">RNAP3</td><td rowspan="1" colspan="1">69</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Diffuse</td><td rowspan="1" colspan="1">ILD</td><td rowspan="1" colspan="1">0.5</td><td rowspan="1" colspan="1">Nucleolar</td><td rowspan="1" colspan="1">1:160</td><td rowspan="1" colspan="1">44</td></tr><tr><td rowspan="1" colspan="1">SSc 159</td><td rowspan="1" colspan="1">CENP</td><td rowspan="1" colspan="1">54</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">Mixed</td><td rowspan="1" colspan="1">Limited</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">Centromere</td><td rowspan="1" colspan="1">1:1280</td><td rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">SSc 177</td><td rowspan="1" colspan="1">CENP</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Limited</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">Discrete speckled</td><td rowspan="1" colspan="1">4+</td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">SSc 194</td><td rowspan="1" colspan="1">CENP</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Limited</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">Discrete speckled</td><td rowspan="1" colspan="1">4+</td><td rowspan="1" colspan="1">6</td></tr><tr><td rowspan="1" colspan="1">SSc 238</td><td rowspan="1" colspan="1">CENP</td><td rowspan="1" colspan="1">53</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Limited</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Centromere</td><td rowspan="1" colspan="1">1:640</td><td rowspan="1" colspan="1">5</td></tr><tr><td rowspan="1" colspan="1">SSc 226</td><td rowspan="1" colspan="1">CENP</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">Asian</td><td rowspan="1" colspan="1">Diffuse</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">Centromere</td><td rowspan="1" colspan="1">1:1280</td><td rowspan="1" colspan="1">6</td></tr><tr><td rowspan="1" colspan="1">HC 162</td><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">HC 400</td><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">HC 117</td><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">HC 118</td><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1">M</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_id778248" class="largeobj-link align_right" style="display: none"><a target="object" href="/articles/PMC4724133/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="id777041">Blank cells indicate information not available at the time of sample collection. <em>ILD</em> interstitial lung disease, <em>PAH</em> pulmonary arterial hypertension, <em>ANA</em> anti-nuclear antibody, <em>MRSS</em> modified Rodnan skin score, <em>SSc</em> systemic sclerosis, <em>M</em> male, <em>F</em> female</p></div></div></div><div id="Sec12" class="sec"><h3 id="Sec12title">Exclusivity and co-occurrence of SSc autoantibodies</h3><p id="id777089" class="p p-first">We observed a high degree of reproducibility between patients within their respective autoantibody groups (TOP1, RNAP3, and CENP; Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>). The greatest degree of overlap between peptides was observed among RNAP3 patients (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1a and c</span></a>), with 420 proteins (54.1&#x000a0;%) detected in all four patients (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1c</span></a>). The remaining groups exhibited significant overlap in three of four (TOP1) and four of five (CENP) patients, respectively (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1a</span></a>), along with a single outlier that showed either higher (SSc 208; TOP1) or lower (SSc 226; CENP) total peptide hits relative to other samples in these groups. Within TOP1, 111 proteins (14.2&#x000a0;%) were detected in all four patients (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1d</span></a>), while CENP exhibited 48 proteins (10.5&#x000a0;%) common to all patients (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1c</span></a>). The least overlap was seen in healthy controls, with only 40 proteins (7.6&#x000a0;%; Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1b</span></a>) common across individuals.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/articles/PMC4724133/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_id739009" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13075_2016_914_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 13075_2016_914_Fig1_HTML.jpg" src="/articles/PMC4724133/bin/13075_2016_914_Fig1_HTML.jpg" /></div><div id="largeobj_id739009" class="largeobj-link align_right" style="display: none"><a target="object" href="/articles/PMC4724133/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/articles/PMC4724133/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Fig. 1</a></div><!--caption a7--><div class="caption"><p id="id777167">Overview of mass spectrometry results. <strong>a</strong> Correlation matrix of non-redundant protein hits for all patients and controls. Comparisons were performed using Fisher&#x02019;s exact test with the Bonferroni correction. <em>Black boxes</em> indicate intra-group comparisons for each of the four clinically defined groups. <em>Green</em> controls; <em>red</em> RNA polymerase III (<em>RNAP3</em>); <em>blue</em> centromere protein (<em>CENP</em>); <em>yellow</em> topoisomerase I (<em>TOP1</em>). <strong>b-f</strong>
<em>Venn diagrams</em> depict overlap in non-redundant peptide hits within and between groups. <strong>b</strong> healthy controls, <strong>c</strong> RNAP3, <strong>d</strong> CENP, <strong>e</strong> TOP1, and <strong>f</strong> overlap between groups</p></div></div></div><p id="id739019">Across all samples, 283 proteins (25.0&#x000a0;%) were detected in at least one patient in each of the four autoantibody groups (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1e</span></a>, Additional file <a href="#MOESM2" rid="MOESM2" class=" media">2</a>: Table S2). Some of these proteins likely represent background signals (serum albumin (ALB), &#x003b2;-tubulin (TUBB), and ribosomal proteins), while others are considered specific to SSc despite trace level detection in controls. For example, multiple SSc autoantibody targets, including Ku (XRCC5 and XRCC6), Ro52/TRIM21, and nucleophosmin/B23 (NPM1) were present in this set of proteins. In contrast, 87 proteins (7.7&#x000a0;%) were detected in all three SSc groups, but were absent in controls (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1e</span></a>; Additional file <a href="#MOESM2" rid="MOESM2" class=" media">2</a>: Table S2). Functional analyses of these proteins revealed strong enrichment of proteins involved in oxidative stress responses and nucleic acid processing (Additional file <a href="#MOESM3" rid="MOESM3" class=" media">3</a>: Table S3B).</p><p id="id739071">Of the 1,130 non-redundant proteins identified, 473 (41.8&#x000a0;%) were unique to a given autoantibody group (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1f</span></a>); however, the vast majority of these proteins were exclusive to a single patient, with only 111 (23.5&#x000a0;%) detected in two or more patients. These results suggest a wide range of autoantibody responses within each of the clinical autoantibody groups beyond what has already been described.</p><p id="id739086">Among the major autoantibody groups, immunoprecipitation of RNAP3 was exclusive to the RNAP3 group, with no RNAP3 peptides detected in any of the other samples (Table&#x000a0;<a href="/articles/PMC4724133/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span>2</span></a>). In contrast, TOP1 peptides were consistently highest among TOP1 patients, but were also detected at low levels in all four RNAP3<sup>+</sup> patients, and in two controls (Table&#x000a0;<a href="/articles/PMC4724133/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span>2</span></a>). As these patients were negative for TOP1 autoantibodies by clinical testing, these results indicate a higher degree of sensitivity for our IP/MS protocol compared to standard ELISA-based methods used clinically. In contrast, CENP was only detected at low levels in the CENP group, likely because it remained bound to the tightly packed centromere complex of chromatin.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="id739125">SSc-associated autoantibodies observed in this study</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_id739128" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1">Alias</th><th rowspan="2" colspan="1">Associated proteins</th><th rowspan="2" colspan="1">Disease subset</th><th rowspan="2" colspan="1">Clinical associations</th><th colspan="4" rowspan="1">Prevalence in this dataset (avg/freq)</th><th rowspan="2" colspan="1">Reference</th></tr><tr><th rowspan="1" colspan="1">Control (n<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="" />=<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="" />4)</th><th rowspan="1" colspan="1">RNAP3 (n<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="" />=<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="" />4)</th><th rowspan="1" colspan="1">TOP1 (n<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="" />=<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="" />4)</th><th rowspan="1" colspan="1">CENP (n<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="" />=<img src="/corehtml/pmc/pmcents/x2009.gif" border="0" alt=" " title="" />5)</th></tr></thead><tbody><tr><td colspan="9" rowspan="1">Major autoantibodies</td></tr><tr><td rowspan="1" colspan="1">RNA Pol III</td><td rowspan="1" colspan="1">POLR3A</td><td rowspan="1" colspan="1">dSSc</td><td rowspan="1" colspan="1">Renal crisis, cancer</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+++ (28/4)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Graf, et al. 2012 [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>]; Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">Scl70</td><td rowspan="1" colspan="1">TOP1</td><td rowspan="1" colspan="1">dSSc</td><td rowspan="1" colspan="1">Poor prognosis, internal organ involvement, and proteinuria</td><td rowspan="1" colspan="1">+ (3/2)</td><td rowspan="1" colspan="1">+ (4/4)</td><td rowspan="1" colspan="1">+++ (19/4)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">Centromere</td><td rowspan="1" colspan="1">
<strong>CENPB</strong>, CENPH</td><td rowspan="1" colspan="1">lSSc/CREST</td><td rowspan="1" colspan="1">PAH, ILD</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (1/2)</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td colspan="9" rowspan="1">Other SSc autoantibodies present in our dataset</td></tr><tr><td rowspan="1" colspan="1">Endothelial Cell</td><td rowspan="1" colspan="1">TUBB, <strong>VCL</strong>, LMNA, RPLP0</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">PAH</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">++ (6/4)</td><td rowspan="1" colspan="1">+ (4/2)</td><td rowspan="1" colspan="1">+ (0/1)</td><td rowspan="1" colspan="1">Dib, et al. 2012 [<a href="#CR34" rid="CR34" class=" bibr popnode">34</a>], Naniwa, et al. 2007 [<a href="#CR35" rid="CR35" class=" bibr popnode">35</a>]</td></tr><tr><td rowspan="1" colspan="1">Fibroblast</td><td rowspan="1" colspan="1">ENO1, G6PD, <strong>HSPA1A</strong>, HSPA1B, VIM</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">PAH</td><td rowspan="1" colspan="1">+ (3/4)</td><td rowspan="1" colspan="1">+++ (12/4)</td><td rowspan="1" colspan="1">++ (5/3)</td><td rowspan="1" colspan="1">++ (8/5)</td><td rowspan="1" colspan="1">Terrier, et al. 2008 [<a href="#CR36" rid="CR36" class=" bibr popnode">36</a>], Terrier, et al. 2009 [<a href="#CR37" rid="CR37" class=" bibr popnode">37</a>]</td></tr><tr><td rowspan="1" colspan="1">Histone</td><td rowspan="1" colspan="1">H1FX, HIST1H1B, <strong>HIST1H4A</strong>
</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">PF, internal organ involvement, decreased survival</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">+ (3/3)</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">B23</td><td rowspan="1" colspan="1">NPM1</td><td rowspan="1" colspan="1">dSSc, CENP- lSSc</td><td rowspan="1" colspan="1">PAH</td><td rowspan="1" colspan="1">+ (4/4)</td><td rowspan="1" colspan="1">++ (7/4)</td><td rowspan="1" colspan="1">++ (5/4)</td><td rowspan="1" colspan="1">++ (6/5)</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">Ku</td><td rowspan="1" colspan="1">
<strong>XRCC5</strong>, XRCC6</td><td rowspan="1" colspan="1">lSSc</td><td rowspan="1" colspan="1">Myositis</td><td rowspan="1" colspan="1">+ (3/3)</td><td rowspan="1" colspan="1">+++ (12/4)</td><td rowspan="1" colspan="1">++ (8/4)</td><td rowspan="1" colspan="1">+ (2/3)</td><td rowspan="1" colspan="1">Graf, et al. 2012 [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>]; Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">Su</td><td rowspan="1" colspan="1">AGO2</td><td rowspan="1" colspan="1">SSc, PM/Scl</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (1/2)</td><td rowspan="1" colspan="1">+ (3/1)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Satoh, et al. 2013 [<a href="#CR38" rid="CR38" class=" bibr popnode">38</a>]</td></tr><tr><td rowspan="1" colspan="1">Mitochondrial (M2)</td><td rowspan="1" colspan="1">
<strong>DLD</strong>, PDHB</td><td rowspan="1" colspan="1">lSSc</td><td rowspan="1" colspan="1">Strong association with primary biliary cirrhosis</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">+ (2/3)</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR13" rid="CR13" class=" bibr popnode">13</a>]</td></tr><tr><td rowspan="1" colspan="1">Pm/Scl</td><td rowspan="1" colspan="1">EXOSC1-<strong>10</strong>
</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">PF, digital ulcers; decreased risk of PAH and GI symptoms</td><td rowspan="1" colspan="1">+ (2/2)</td><td rowspan="1" colspan="1">++ (5/3)</td><td rowspan="1" colspan="1">+ (2/2)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR13" rid="CR13" class=" bibr popnode">13</a>]</td></tr><tr><td rowspan="1" colspan="1">hnRNPs</td><td rowspan="1" colspan="1">
<strong>HNRNPA1</strong>-3, HNRNPL</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">Common in SARDs</td><td rowspan="1" colspan="1">+ (0/1)</td><td rowspan="1" colspan="1">++ (7/4)</td><td rowspan="1" colspan="1">+ (3/4)</td><td rowspan="1" colspan="1">+ (2/4)</td><td rowspan="1" colspan="1">Siapka, et al. 2007 [<a href="#CR39" rid="CR39" class=" bibr popnode">39</a>]</td></tr><tr><td rowspan="1" colspan="1">U1</td><td rowspan="1" colspan="1">
<strong>SNRNPA</strong>, SPRNP70</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">Co-occurrence with SS-A/SS-B, PAH, overlap syndrome</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (2/4)</td><td rowspan="1" colspan="1">+ (1/2)</td><td rowspan="1" colspan="1">+ (0/1)</td><td rowspan="1" colspan="1">Graf, et al. 2012 [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>]; Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">U5</td><td rowspan="1" colspan="1">SNRNP200</td><td rowspan="1" colspan="1">SSc, PM/Scl</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">++ (6/3)</td><td rowspan="1" colspan="1">++ (9/4)</td><td rowspan="1" colspan="1">++ (8/3)</td><td rowspan="1" colspan="1">+ (1/2)</td><td rowspan="1" colspan="1">Kubo, et al. 2002 [<a href="#CR40" rid="CR40" class=" bibr popnode">40</a>]</td></tr><tr><td rowspan="1" colspan="1">RO52/TRIM21</td><td rowspan="1" colspan="1">TRIM21</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">ILD, other autoimmune diseases</td><td rowspan="1" colspan="1">++ (6/3)</td><td rowspan="1" colspan="1">+++ (12/4)</td><td rowspan="1" colspan="1">++ (6/4)</td><td rowspan="1" colspan="1">++ (8/4)</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">RuvB</td><td rowspan="1" colspan="1">
<strong>RUVBL1</strong>, RUVBL2</td><td rowspan="1" colspan="1">dSSc</td><td rowspan="1" colspan="1">Common in SARDs, older age at onset, male sex</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">++ (7/4)</td><td rowspan="1" colspan="1">+ (3/4)</td><td rowspan="1" colspan="1">+ (2/4)</td><td rowspan="1" colspan="1">Kaji, et al. 2014 [<a href="#CR18" rid="CR18" class=" bibr popnode">18</a>]</td></tr><tr><td rowspan="1" colspan="1">Annexin V</td><td rowspan="1" colspan="1">ANXA5</td><td rowspan="1" colspan="1">dSSc, CENP- lSSc</td><td rowspan="1" colspan="1">Digital ischemia</td><td rowspan="1" colspan="1">+ (2/2)</td><td rowspan="1" colspan="1">++ (7/4)</td><td rowspan="1" colspan="1">+ (4/3)</td><td rowspan="1" colspan="1">+ (3/4)</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">SS-B/LA</td><td rowspan="1" colspan="1">SS-A, <strong>SS-B</strong>
</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">ILD, other autoimmune diseases</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (3/4)</td><td rowspan="1" colspan="1">+ (2/2)</td><td rowspan="1" colspan="1">+ (0/1)</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">Peroxiredoxin</td><td rowspan="1" colspan="1">PRDX1</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">Disease duration, PF, cardiac involvement, TOP1+ patients</td><td rowspan="1" colspan="1">+ (2/4)</td><td rowspan="1" colspan="1">++ (8/4)</td><td rowspan="1" colspan="1">+ (3/3)</td><td rowspan="1" colspan="1">+ (4/4)</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">hUBF/NOP90</td><td rowspan="1" colspan="1">UBTF</td><td rowspan="1" colspan="1">lSSc</td><td rowspan="1" colspan="1">Mild organ involvement, favorable prognosis</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (1/2)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">Th/To</td><td rowspan="1" colspan="1">POP1</td><td rowspan="1" colspan="1">lSSc</td><td rowspan="1" colspan="1">PF, renal crisis, poor prognosis, myositis, PAH</td><td rowspan="1" colspan="1">+ (1/2)</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">+ (3/3)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Graf, et al. 2012 [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>]; Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">PL-12</td><td rowspan="1" colspan="1">AARS</td><td rowspan="1" colspan="1">SSc, PM/DM</td><td rowspan="1" colspan="1">ILD without myositis</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">Hamaguchi, et al. 2013 [<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>]</td></tr><tr><td rowspan="1" colspan="1">OJ</td><td rowspan="1" colspan="1">IARS</td><td rowspan="1" colspan="1">SSc, PM/DM</td><td rowspan="1" colspan="1">ILD without myositis</td><td rowspan="1" colspan="1">+ (1/1)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (3/3)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Hamaguchi, et al. 2013 [<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>]</td></tr><tr><td rowspan="1" colspan="1">EJ</td><td rowspan="1" colspan="1">GARS</td><td rowspan="1" colspan="1">SSc, PM/DM</td><td rowspan="1" colspan="1">ILD, myositis</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (3/4)</td><td rowspan="1" colspan="1">+ (2/2)</td><td rowspan="1" colspan="1">+ (0/1)</td><td rowspan="1" colspan="1">Hamaguchi, et al. 2013 [<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>]</td></tr><tr><td rowspan="1" colspan="1">Jo-1</td><td rowspan="1" colspan="1">HARS</td><td rowspan="1" colspan="1">SSc, PM/DM</td><td rowspan="1" colspan="1">ILD, myositis</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (1/4)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Hamaguchi, et al. 2013 [<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>]</td></tr><tr><td rowspan="1" colspan="1">PL-7</td><td rowspan="1" colspan="1">TARS</td><td rowspan="1" colspan="1">SSc, PM/DM</td><td rowspan="1" colspan="1">ILD, myositis</td><td rowspan="1" colspan="1">+ (2/2)</td><td rowspan="1" colspan="1">++ (8/4)</td><td rowspan="1" colspan="1">++ (6/4)</td><td rowspan="1" colspan="1">+ (2/4)</td><td rowspan="1" colspan="1">Hamaguchi, et al. 2013 [<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>]</td></tr><tr><td rowspan="1" colspan="1">Ha</td><td rowspan="1" colspan="1">YARS</td><td rowspan="1" colspan="1">SSc, PM/DM</td><td rowspan="1" colspan="1">Interstitial pneumonia</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (0/1)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Hashish, et al 2005 [<a href="#CR41" rid="CR41" class=" bibr popnode">41</a>]</td></tr><tr><td rowspan="1" colspan="1">Zo</td><td rowspan="1" colspan="1">
<strong>FARSA</strong>, FARSB</td><td rowspan="1" colspan="1">SSc, PM/Scl</td><td rowspan="1" colspan="1">Anti-synthetase syndrome</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">+ (2/4)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Betteridge, et al. 2007 [<a href="#CR42" rid="CR42" class=" bibr popnode">42</a>]</td></tr><tr><td colspan="9" rowspan="1">SSc autoantibodies not detected in our dataset</td></tr><tr><td rowspan="1" colspan="1">Fibrillarin</td><td rowspan="1" colspan="1">U3RNP</td><td rowspan="1" colspan="1">dSSc</td><td rowspan="1" colspan="1">More frequent in blacks; severe disease, poor prognosis</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">U11/U12 RNP</td><td rowspan="1" colspan="1">SNRNP35</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">Lung fibrosis, gastrointestinal involvement</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mimori, 1999 [<a href="#CR43" rid="CR43" class=" bibr popnode">43</a>]</td></tr><tr><td rowspan="1" colspan="1">PDGFR</td><td rowspan="1" colspan="1">PDGFR</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Svegliati Baroni, et al. 2006 [<a href="#CR44" rid="CR44" class=" bibr popnode">44</a>]</td></tr><tr><td rowspan="1" colspan="1">MMP</td><td rowspan="1" colspan="1">MMP family</td><td rowspan="1" colspan="1">dSSc</td><td rowspan="1" colspan="1">Skin, lung, and vascular fibrosis</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">tPA</td><td rowspan="1" colspan="1">PLAT</td><td rowspan="1" colspan="1">lSSc</td><td rowspan="1" colspan="1">PAH</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">IFI16</td><td rowspan="1" colspan="1">IFI16</td><td rowspan="1" colspan="1">lSSc</td><td rowspan="1" colspan="1">Common in SARDs</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">Fibrillin 1</td><td rowspan="1" colspan="1">FBN1</td><td rowspan="1" colspan="1">dSSc</td><td rowspan="1" colspan="1">Choctaw and Japanese patients; absent in Caucasians</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">Vascular Receptors</td><td rowspan="1" colspan="1">AGTR2, EDN1</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">TOP1+ patients, renal crisis</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr><tr><td rowspan="1" colspan="1">ATF2</td><td rowspan="1" colspan="1">ATF2</td><td rowspan="1" colspan="1">SSc</td><td rowspan="1" colspan="1">Longer disease duration, decreased lung function</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">Mehra, et al. 2013 [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>]</td></tr></tbody></table></div><div id="largeobj_id739128" class="largeobj-link align_right" style="display: none"><a target="object" href="/articles/PMC4724133/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="id768951">Data are presented as the average of all peptide hits across each autoantibody group, followed by the frequency of peptide detection within the group. For autoantibodies known to target more than one protein or subunit, data for a single representative protein are shown, with the specific protein highlighted in bold. Associated proteins indicate specific protein targets identified in this study; among autoantibodies not identified here, the most common targets are listed. Symbols: -, +, ++, and +++ indicate an average of 0, 1&#x02013;4, 5&#x02013;9, and &#x02265;10 peptide hits per group, respectively</p><p id="id768958">
<em>SSc</em> systemic sclerosis, <em>lSSc</em> limited cutaneous SSc, <em>dSSc</em> diffuse cutaneous SSc, <em>PAH</em> pulmonary arterial hypertension; <em>ILD</em> interstitial lung disease; <em>CREST</em> CREST syndrome (calcinosis, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia); <em>PM/Scl</em> polymyositis/scleroderma, <em>PM/DM</em> polymyositis/dermatomyositis</p></div></div><p id="id769007">Other known SSc autoantigens were also detected. RuvBL [<a href="#CR18" rid="CR18" class=" bibr popnode">18</a>] was strongly detected in all SSc samples, while virtually absent in controls. Ku and Su, along with a wide array of anti-tRNA synthetases [<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>] were routinely detected in both the RNAP3 and TOP1 subsets, but were only weakly present in the CENP and control groups (Table&#x000a0;<a href="/articles/PMC4724133/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span>2</span></a>).</p><p id="id769038" class="p p-last">Several autoantigens previously implicated in SSc were found at low, background levels in both SSc and control samples. Ro52/TRIM21 [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>] and nucleophosmin/B23 [<a href="#CR21" rid="CR21" class=" bibr popnode">21</a>] were widely detected across all four groups, suggesting widespread reactivity to these proteins in SSc and controls. We did not find evidence in SSc of enrichment of Pm/Scl autoantibodies, which target exosome components EXOSC1-10 [<a href="#CR22" rid="CR22" class=" bibr popnode">22</a>]. Peptides for these proteins were absent in the CENP group, but were detected at low levels in other subsets, including controls. Autoantigens not detected here include many of the URNPs, PDGFR, matrix metalloproteinases, tissue plasminogen activator, and vascular receptor antibodies (Table&#x000a0;<a href="/articles/PMC4724133/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span>2</span></a>).</p></div><div id="Sec13" class="sec"><h3 id="Sec13title">Functional clustering of identified proteins</h3><p id="id769089" class="p p-first-last">To identify functional interactions among autoantigens, all 763 non-redundant protein hits were submitted as a query to the GIANT global average network. This approach included both SSc-specific targets and those detected at background levels in controls, to better understand the full range of autoreactive proteins and complexes. Nine distinct communities were identified within the resulting network, in which each gene is represented by a node, and two genes share an edge if they are predicted to functionally interact (Additional file <a href="#MOESM4" rid="MOESM4" class=" media">4</a>: Figure S1). Analysis of each of these communities by g:Profiler revealed functional enrichment for a wide range of biological processes associated with important disease processes and components (Additional file <a href="#MOESM4" rid="MOESM4" class=" media">4</a>: Figure S1). Community 1 is dominated by ribosomal proteins, eukaryotic initiation factor 3 (eIF3) subunits, and includes the SSc autoantibody target nucleophosmin/B23. Communities 2 and 8 show strong enrichment for Gene Ontology (GO) terms mRNA processing, ribonucleoprotein complex, and cytosolic stress granule. Community 2 is dominated primarily by DEAD box helicases proteins, while community 8 contains a diverse array of proteins including multiple SSc autoantibodies, including TOP1, SSB, Pm/Scl proteins, URNPs, and HNRNPs, and numerous serine/arginine-rich splicing factors. Community 3 consists primarily of aminoacyl tRNA synthetases, a cluster often targeted in autoimmune diseases [<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>, <a href="#CR23" rid="CR23" class=" bibr popnode">23</a>]. Communities 4, 5, and 9 are strongly associated with a variety of GO processes known to play a major role in SSc, including wound healing, IFN signaling, and response to oxidative stress. Major proteins include CD44, HLAs, myosins, and filamin proteins in community 4 and tricarboxylic acid cycle proteins in community 5. Community 9 contains multiple protein disulfide isomerases and peroxiredoxins, protein folding enzymes such as calnexin (CANX) and calreticulin (CALR), and the major collagen processing enzyme prolyl 4-hydroxylase beta (P4HB). Community 6 contains multiple annexin and 14-3-3 proteins; enriched GO processes include ribonucleoprotein complex assembly, mitochondrial transport, RNA processing, and anchoring junction. Community 7 associated with GO terms include cell cycle, RNA polymerase III complex, DNA-PK-Ku complex, and antigen processing and presentation. Community 7 includes several SSc autoantibody targets including Ku proteins XRCC5 and 6, RUVBL1 and 2, RNA polymerase I and II subunits, multiple proteasomal subunits, and T-complex proteins.</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">Preferential detection of autoantibodies in SSc</h3><p id="id769155" class="p p-first-last">Subsequent comparisons between groups were performed in a semiquantitative manner based on the presence or absence of a given protein in an immunoprecipitant, with quantitative analyses limited to comparisons within an individual sample. To identify biological processes and cellular components differentially targeted in SSc, with minimal to no background detection in controls, we examined all proteins detected in &#x0003e;50&#x000a0;% of SSc samples at a frequency &#x0003e;1.5-fold relative to controls, resulting in a list of 137 differentially detected proteins (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>; Additional file <a href="#MOESM2" rid="MOESM2" class=" media">2</a>: Table S2). Enriched biological processes included <em>ncRNA metabolic process</em>, response to oxygen radical, and triglyceride-rich lipoprotein particle remodeling. Preferentially targeted cellular components include cytosolic stress granule, lipid-protein complex<em>,</em> pigment granule, and anchoring junction; molecular functions include antioxidant activity and mRNA binding (Additional file <a href="#MOESM3" rid="MOESM3" class=" media">3</a>: Table S3C).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/articles/PMC4724133/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_id769233" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13075_2016_914_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 13075_2016_914_Fig2_HTML.jpg" src="/articles/PMC4724133/bin/13075_2016_914_Fig2_HTML.jpg" /></div><div id="largeobj_id769233" class="largeobj-link align_right" style="display: none"><a target="object" href="/articles/PMC4724133/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/articles/PMC4724133/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Fig. 2</a></div><!--caption a7--><div class="caption"><p id="id769214">Proteins differentially detected in systemic sclerosis (<em>SSc</em>). Semiquantitative enrichment of SSc-associated autoantibodies was determined using a binary assessment of autoantibody presence or absence in a sample. Preferential enrichment in SSc was defined as all proteins detected in &#x0003e;50&#x000a0;% of all patient samples at a frequency &#x0003e;1.5-fold relative to controls. <strong>a</strong> Heat map of proteins differentially detected in SSc. <strong>b</strong> Network analysis of differentially detected proteins. Community detection was performed using the GIANT global network; functional annotation was performed using gProfiler</p></div></div></div></div><div id="Sec15" class="sec"><h3 id="Sec15title">RNA processing centers are major targets of SSc autoantibodies</h3><p id="id769250" class="p p-first">The strong enrichment for GO terms associated with mRNA processing and stress response, as well as the identification of cytosolic stress granule as an enriched cellular component, led us to further investigate the role of stress granules (SG) and RNA processing bodies (PB) in the autoantibody response of SSc. SG and PB represent distinct, non-membranous cytoplasmic entities, which arise in response to different cellular stresses including oxidative stress, hypoxia, viral infection, unfolded proteins, and amino acid deprivation [<a href="#CR24" rid="CR24" class=" bibr popnode">24</a>]. These structures exist in constant flux, driven by the availability of constituent mRNPs, regulating the fate of untranslated mRNAs in response to translational arrest [<a href="#CR25" rid="CR25" class=" bibr popnode">25</a>]. While SG are generally absent under normal conditions, PB are constitutively present at low levels due to their role as microRNA processing centers. Both structures have been shown to arise in response to cellular stresses, including oxidative stress, ischemia, and cancer [<a href="#CR26" rid="CR26" class=" bibr popnode">26</a>], all of which are known to be important in SSc pathogenesis [<a href="#CR5" rid="CR5" class=" bibr popnode">5</a>, <a href="#CR27" rid="CR27" class=" bibr popnode">27</a>].</p><p id="id466139" class="p p-last">In addition to the 137 differentially detected proteins described above, a wide range of PB/SG constituents were readily detected across most SSc samples (Additional file <a href="#MOESM5" rid="MOESM5" class=" media">5</a>: Table S4). Substantial reactivity was seen against PB components such as UPF1 and MOV10, and SG proteins FXR1 and FXR2, G3BP1 and G3BP2, and USP10. Only background levels of reactivity were seen in healthy controls.</p></div><div id="Sec16" class="sec sec-last"><h3 id="Sec16title">Validation of PB/SG antibodies in SSc</h3><p id="id466161" class="p p-first">In order to validate the differential abundance of PB/SG proteins identified by LC-MS/MS, HeLa whole cell lysates were immunoprecipitated using antibodies from each patient as described in the LC-MS/MS analyses. Western blots were performed by resolving equal volumes of IP eluates by SDS-PAGE and transferring to nitrocellulose. Blots were then probed with antibodies targeting PB/SG proteins UPF1, MOV10, CAPRIN1, G3BP1, and USP10. These targets were chosen based upon their high level of detection across SSc groups, as determined based on our LC-MS/MS data. Strong reactivity was seen against all five proteins in SSc with only trace levels detected in controls (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3a</span></a>), indicating widespread immune responses against these protein complexes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/articles/PMC4724133/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_id466233" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13075_2016_914_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 13075_2016_914_Fig3_HTML.jpg" src="/articles/PMC4724133/bin/13075_2016_914_Fig3_HTML.jpg" /></div><div id="largeobj_id466233" class="largeobj-link align_right" style="display: none"><a target="object" href="/articles/PMC4724133/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/articles/PMC4724133/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Fig. 3</a></div><!--caption a7--><div class="caption"><p id="id466189">Validation of RNA processing bodies (<em>PB</em>)/stress granules (<em>SG</em>) as a target of the SSc autoimmune response. <strong>a</strong> HeLa cell lysates were immunoprecipitated using patient sera, resolved by SDS-PAGE, and probed with antibodies targeting known PB and SG proteins; HeLa whole cell lysate was used as a control. <strong>b</strong> Immunofluorescence was performed in U2OS cells treated with sodium (meta)arsenite to induce the formation of SG. Cells were then fixed with 4&#x000a0;% paraformaldehyde and permeabilized with 5&#x000a0;% normal horse serum and 0.1&#x000a0;% digitonin in Tris-buffered saline. Staining was performed with anti-eIF3b (SG marker), anti-SK1-Hedls (PB marker), and patient sera. Representative images depicting co-localization between patient sera and SG/PB markers are shown, with sites of co-localization circled in <em>red. RNAP</em> RNA polymerase, <em>CENP</em> centromere protein <em>TOPI</em> topoisomerase I</p></div></div></div><p id="id466244" class="p p-last">Further validation was performed using immunofluorescence (IF) staining of U2OS cells maintained under conditions of oxidative stress to induce PB/SG formation. Cells were probed with patient sera in combination with PB and SG markers SK1-Hedls and eIF3b, respectively. Co-localization between patient sera and PB/SG markers was observed in six of nine SSc patients, with at least one positive sample in each of the three autoantibody groups; no staining was seen for any of the three healthy controls (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3b</span></a>). These results are consistent with that seen on LC-MS/MS, particularly among RNAP3 patients, who exhibited the strongest and most consistent autoantibody responses across both methods. Taken together, these data strongly implicate PB/SG as novel targets of SSc autoantibody responses.</p></div></div><div id="Sec17" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec17title">Discussion</h2><p id="id466269" class="p p-first">Autoantibodies have long been used in the diagnosis of SSc, with different autoantibodies predictive of clinical outcomes, including interstitial lung disease, pulmonary arterial hypertension, and skin involvement. While a wide array of SSc-associated autoantibodies have been described, diagnoses are often performed based upon the presence or absence of reactivity against three proteins: RNAP3, TOP1, and CENP. The data presented here suggest a much broader autoantibody response, which is reflective of underlying disease pathologies. Strong subset-specific reactivity was evident against both RNAP3 and TOP1, with no RNAP3 peptides detected in any of the other groups; however, all four RNAP3 patients exhibited modest reactivity against TOP1, indicating a degree of overlap between these two autoantibody groups. When peptides recovered are extended beyond the three major targets, we found substantial overlap across the three major SSc groups. We found peptides from the autoantigens of RuvBL1/2, which appear to act as general markers of SSc, with consistent detection across all SSc groups, with almost no reactivity seen in controls. In contrast, some common SSc autoantigens such as B23 and Ro52/TRIM21 were recovered in virtually all samples, and in controls, indicating an important degree of baseline reactivity against some of the more common autoantibody targets.</p><p id="id466283">In this proof-of-concept study, we do not attempt to address the clinical implications of the autoantibody responses described here due to the limited number of patients analyzed, nor are we able to speculate on the presence or absence of these autoantibodies in other SSc autoantibody groups. Our depth in this study comes from the number of potential antigens analyzed, which cover the full proteome. Future studies examining a much larger cohort of SSc patients, along with representatives of other autoimmune diseases, will be necessary to determine the clinical value of these potential autoantibodies.</p><p id="id466290">This is not the first study to suggest the presence of multiple autoantibodies in SSc. Immunoassays performed by Op De Beeck, et al. revealed the presence of multiple autoantibodies in a small subset of SSc patients [<a href="#CR28" rid="CR28" class=" bibr popnode">28</a>]. A similar analysis by Graf et al. using the EUROLINE immunoassay revealed the presence of multiple autoantibodies in 11&#x000a0;% of patients [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>].</p><p id="id466314">Autoantibodies against extracellular immune signaling receptors and extracellular matrix proteins were conspicuously absent in these data; this includes the absence of numerous autoantibodies previously implicated in SSc pathogenesis, such as anti-fibrillin 1, anti-MMP, and anti-PDGFR [<a href="#CR29" rid="CR29" class=" bibr popnode">29</a>]. Additional analyses in other cell types, such as fibroblasts or endothelial cells, and cells maintained under physiologically relevant growth conditions, such as immune activation or oxidative stress, may be useful for identifying other proteins and complexes which may play a role in disease pathogenesis.</p><p id="id466330">In addition to identifying novel autoantibody targets, the unbiased nature of mass spectrometry provides additional insights into the processes potentially underlying autoimmunity. The preferential detection of proteins associated with RNA processing and oxidative stress as a general feature of SSc autoantibodies may be indicative of their origins. Combined with the consistent targeting of PB/SG described here spanning all SSc patients, these data suggest a basic model in which disease-specific pathologies give rise to specific autoantibodies. Strong induction of SGs is observed in response to cellular stresses, including oxidative stress and ischemia, two well-established phenomena in SSc [<a href="#CR27" rid="CR27" class=" bibr popnode">27</a>]. SG/PB are also readily induced in response to the tumor microenvironment, consistent with recent evidence linking RNAP3-positive SSc and cancer [<a href="#CR5" rid="CR5" class=" bibr popnode">5</a>, <a href="#CR30" rid="CR30" class=" bibr popnode">30</a>]. Combined with evidence linking transforming growth factor (TGF)-&#x003b2; signaling with an increase in PB formation [<a href="#CR31" rid="CR31" class=" bibr popnode">31</a>], many of the major processes underlying SSc pathogenesis appear broadly consistent with an immune response against cells undergoing a stress response. PBs are also known to associate with other cytoplasmic structures, such as U bodies [<a href="#CR32" rid="CR32" class=" bibr popnode">32</a>], which house an number of well-established SSc autoantibody targets, including U1, U5, and U11/U12. Taken together, these data suggest a model in which autoantibodies arise as a secondary phenotype in response to SSc-related processes already underway.</p><p id="id466391">Some evidence suggesting a link between PBs and autoimmunity has been described previously. Bhanji, et al. observed reactivity against a number of PB-associated proteins, including GE1/<em>Hedls</em>, GW182, and Ago2 in a range of autoimmune diseases, including SSc [<a href="#CR33" rid="CR33" class=" bibr popnode">33</a>]. Among these autoantigens, only Ago2 was also identified in this analysis, suggesting a persistent, yet diverse response against this complex. A similar analysis of SG-associated proteins has not been performed; however given the reactivity to PB proteins seen in other autoimmune diseases, reactivity in other autoimmune diseases is possible. A detailed analysis using both mass spectrometry and other methods will be necessary to understand the degree to which autoantibodies to SG/PBs are seen in other autoimmune diseases, and the clinical implications of these findings.</p><p id="id466415" class="p p-last">This work has several limitations. First, we cannot eliminate the possibility that some proteins found in our mass spectrometry data result from co-IP of multi-protein complexes by a single autoantibody; however, we were able to confirm the presence of multiple PB/SG autoantibodies by other means (Fig.&#x000a0;<a href="/articles/PMC4724133/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>). We also cannot rule out the possibility that some targets were missed due to their being sequestered into tightly packed molecular complexes associated with chromatin. For example, the presence of CENP autoantibodies within these samples had been established using clinical methods, indicating its absence in our mass spectrometry data is likely a result of its sequestration into large macromolecular complexes with limited solubility. A lack of age- and gender-matched controls likely underestimates the degree of baseline reactivity seen in unaffected controls. Finally, the small number of patient samples used in this study prevents any clinical interpretation, and the variability in the number of peptides recovered between experiments limits direct quantitative comparisons between autoantibody groups.</p></div><div id="Sec18" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec18title">Conclusions</h2><p id="id466444" class="p p-first-last">The data presented here provide evidence of diverse immune reactivities in SSc targeting a wide array of protein complexes. Among these complexes, autoantibodies targeting PB/SG were consistently identified across both clinical SSc subsets and major autoantibody groups, suggesting a potential novel autoantibody target. Taken together, these data suggest immune responses to proteins involved in cellular stress may be a common mechanism for autoantibody generation.</p></div><div id="id766180" class="tsec sec"><h2 class="head no_bottom_margin" id="id766180title">Acknowledgements</h2><div class="sec"><p id="id766184">This work was supported by grants from the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Center of Research Translation (P50 AR060780 to MLW and RL), the Department of Defense (PR130908 to MLW), and a SYNERGY grant from the Geisel School of Medicine at Dartmouth (to MLW). JNT is supported in part by a grant from the National Institute of General Medical Sciences (NIGMS; T32GM008704). SAG is supported by grants R01-CA155260 and S10-OD016212 from the NIH. JKG is supported by a Kellen Foundation Clinician Scientist Development Award from the Hospital for Special Surgery. Written informed consent was obtained from all participants for publication of their individual details in this manuscript. All consent forms are held by the respective authors&#x02019; institutions and are available for review by the Editor-in-Chief.</p></div></div><div id="id766034" class="tsec sec"><h2 class="head no_bottom_margin" id="id766034title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>CENP</td><td>centromere protein</td></tr><tr><td>DMEM</td><td>Dulbecco&#x02019;s modified Eagle&#x02019;s medium</td></tr><tr><td>dSSc</td><td>diffuse systemic sclerosis</td></tr><tr><td>ELISA</td><td>enzyme-linked immunosorbent assay</td></tr><tr><td>FBS</td><td>fetal bovine serum</td></tr><tr><td>GIANT</td><td>Genome-scale Integrated Analysis of gene Networks in Tissues</td></tr><tr><td>IFN</td><td>interferon</td></tr><tr><td>kDa</td><td>kiloDalton</td></tr><tr><td>LC-MS/MS</td><td>liquid chromatography tandem-mass spectrometry</td></tr><tr><td>IP</td><td>immunoprecipitation</td></tr><tr><td>lSSc</td><td>limited systemic sclerosis</td></tr><tr><td>PB</td><td>RNA processing bodies</td></tr><tr><td>PBS</td><td>phosphate-buffered saline</td></tr><tr><td>RNAP3</td><td>RNA polymerase III</td></tr><tr><td>SG</td><td>stress granules</td></tr><tr><td>SSc</td><td>systemic sclerosis</td></tr><tr><td>TOP1</td><td>topoisomerase I</td></tr></tbody></table></div></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec19" class="sec sec-first"><h3 id="Sec19title">Additional files</h3><p id="id466462" class="p p-first-last"><span class="sup-box" id="MOESM1"><a href="/articles/PMC4724133/bin/13075_2016_914_MOESM1_ESM.xls" data-ga-action="click_feat_suppl">Additional file 1: Table S1.</a><sup>(639K, xls)</sup><p id="id466477">Complete list of peptides identified in this analysis. <em>TP</em> number of total peptides mapping to a protein, <em>UP</em> number of unique peptides mapping to a protein, <em>UM</em> number of non-redundant peptides mapping exclusively to a protein, <em>MW</em> molecular weight, <em>Length</em> protein length in amino acids. (XLS 639 kb)</p></span><span class="sup-box" id="MOESM2"><a href="/articles/PMC4724133/bin/13075_2016_914_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl">Additional file 2: Table S2.</a><sup>(17K, xlsx)</sup><p id="id765940">Gene lists used in these analyses. (XLSX 17 kb)</p></span><span class="sup-box" id="MOESM3"><a href="/articles/PMC4724133/bin/13075_2016_914_MOESM3_ESM.ods" data-ga-action="click_feat_suppl">Additional file 3: Table S3.</a><sup>(70K, ods)</sup><p id="id765956">Systemic sclerosis (SSc)-specific enrichment of processes and components. Proteins differentially detected in SSc were analyzed using gProfiler. Statistically significant processes and components are shown. A) Peptides detected at any level across all four groups. B) Peptides identified in all SSc groups, but absent in controls. C) Analysis of 137 proteins differentially detected in SSc. <em>BP</em> biological process, <em>CC</em> cellular component, <em>MF</em> molecular function, <em>ke</em> KEGG pathway, <em>re</em> REACTOME pathway. (ODS 70 kb)</p></span><span class="sup-box" id="MOESM4"><a href="/articles/PMC4724133/bin/13075_2016_914_MOESM4_ESM.eps" data-ga-action="click_feat_suppl">Additional file 4: Figure S1.</a><sup>(1.8M, eps)</sup><p id="id766004">Network analysis of systemic sclerosis (SSc) autoantigens. All 763 non-redundant peptide hits identified in two or more patients were analyzed using the Genome-scale Integrated Analysis of gene Networks in Tissues (GIANT) global network to identify functionally associated protein networks. Analysis of community function was performed using gProfiler. SSc-associated autoantibodies are highlighted in <em>yellow</em>. (EPS 1902 kb)</p></span><span class="sup-box" id="MOESM5"><a href="/articles/PMC4724133/bin/13075_2016_914_MOESM5_ESM.ods" data-ga-action="click_feat_suppl">Additional file 5: Table S4.</a><sup>(21K, ods)</sup><p id="id766030">Processing body and stress granule proteins identified in this analysis. *Proteins with multiple subunits. Data indicate non-redundant peptide hits. (ODS 20 kb)</p></span></p></div></div><div id="id766155" class="tsec sec"><h2 class="head no_bottom_margin" id="id766155title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="id766156"><p id="id766157" class="p p-first"><strong>Competing interests</strong></p><p id="id766160" class="p p-last">Dr. Whitfield has received royalties for patents regarding gene expression biomarkers in Scleroderma and is a scientific founder of Celdara Medical LLC. Dr. Lafyatis has received both grants and consulting fees from Genzyme/Sanofi, Shire, Regeneron, Biogen, BMS, Inception, Precision Dermatology, PRISM, UCB, Pfizer and Roche/Genentech; he received consulting fees from Lycera, Novartis, Celgene, Amira, Celdara, Celltex, Dart Therapeutics, Idera, Intermune, Medimmune, Promedior, Zwitter, Actelion, EMD Serono, Akros, Extera, Reneo, Scholar Rock, and HGS. No authors have any non-financial conflicts of interest to report.</p></p><p class="fn sec" id="id766168"><p id="id766169" class="p p-first"><strong>Authors&#x02019; contributions</strong></p><p id="id766173" class="p p-last">MEJ conceived of the study, performed experiments, analyzed data, and wrote the manuscript. AVG performed mass spectrometry and helped to revise the manuscript. JNT performed data analysis and helped to revise the manuscript. SML performed immunofluorescence experiments, and helped to revise the manuscript. DS performed mass spectrometry, and revised the manuscript. JKG, RFS, and RL provided clinical samples, and revised the manuscript. PJA designed experiments, provided technical assistance, and revised the manuscript. SAG and MLW conceived of the study, participated in its design, and helped to revise the manuscript. All authors read and approved the final manuscript.</p></p></div></div><div id="id463789aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="id463789aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Michael E. Johnson, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htuomtrad@nosnhoj.e.leahcim" class="oemail">ude.htuomtrad@nosnhoj.e.leahcim</a></span>.</p><p><span class="fm-affl">Andrew V. Grassetti, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htuomtrad@rg.ittessarg.v.werdna" class="oemail">ude.htuomtrad@rg.ittessarg.v.werdna</a></span>.</p><p><span class="fm-affl">Jaclyn N. Taroni, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htuomtrad@rg.inorat.n.nylcaj" class="oemail">ude.htuomtrad@rg.inorat.n.nylcaj</a></span>.</p><p><span class="fm-affl">Shawn M. Lyons, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.srentrap@snoylms" class="oemail">gro.srentrap@snoylms</a></span>.</p><p><span class="fm-affl">Devin Schweppe, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@pewhcskd" class="oemail">ude.wu@pewhcskd</a></span>.</p><p><span class="fm-affl">Jessica K. Gordon, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ssh@jnodrog" class="oemail">ude.ssh@jnodrog</a></span>.</p><p><span class="fm-affl">Robert F. Spiera, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ssh@rareips" class="oemail">ude.ssh@rareips</a></span>.</p><p><span class="fm-affl">Robert Lafyatis, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@sitayfalr" class="oemail">moc.liamg@sitayfalr</a></span>.</p><p><span class="fm-affl">Paul J. Anderson, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.hwb.scir@nosrednap" class="oemail">ude.dravrah.hwb.scir@nosrednap</a></span>.</p><p><span class="fm-affl">Scott A. Gerber, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htuomtrad@rebreg.a.ttocs" class="oemail">ude.htuomtrad@rebreg.a.ttocs</a></span>.</p><p><span class="fm-affl">Michael L. Whitfield, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htuomtrad@dleiftihw.l.leahcim" class="oemail">ude.htuomtrad@dleiftihw.l.leahcim</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Graf SW, Hakendorf P, Lester S, Patterson K, Walker JG, Smith MD, et al.  South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome. <span><span class="ref-journal">Int J Rheum Dis. </span>2012;<span class="ref-vol">15</span>:102–9. doi: 10.1111/j.1756-185X.2011.01688.x.</span> [<a href="http://europepmc.org/abstract/MED/22324953" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1756-185X.2011.01688.x" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Rheum+Dis&amp;title=South+Australian+Scleroderma+Register:+autoantibodies+as+predictive+biomarkers+of+phenotype+and+outcome&amp;author=SW+Graf&amp;author=P+Hakendorf&amp;author=S+Lester&amp;author=K+Patterson&amp;author=JG+Walker&amp;volume=15&amp;publication_year=2012&amp;pages=102-9&amp;pmid=22324953&amp;doi=10.1111/j.1756-185X.2011.01688.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Steen VD. Autoantibodies in systemic sclerosis. <span><span class="ref-journal">Semin Arthritis Rheum. </span>2005;<span class="ref-vol">35</span>:35–42. doi: 10.1016/j.semarthrit.2005.03.005.</span> [<a href="http://europepmc.org/abstract/MED/16084222" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.semarthrit.2005.03.005" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Arthritis+Rheum.&amp;title=Autoantibodies+in+systemic+sclerosis&amp;author=VD+Steen&amp;volume=35&amp;publication_year=2005&amp;pages=35-42&amp;pmid=16084222&amp;doi=10.1016/j.semarthrit.2005.03.005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Mehra S, Walker J, Patterson K, Fritzler MJ. Autoantibodies in systemic sclerosis. <span><span class="ref-journal">Autoimmun Rev. </span>2013;<span class="ref-vol">12</span>:340–54. doi: 10.1016/j.autrev.2012.05.011.</span> [<a href="http://europepmc.org/abstract/MED/22743034" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.autrev.2012.05.011" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmun+Rev&amp;title=Autoantibodies+in+systemic+sclerosis&amp;author=S+Mehra&amp;author=J+Walker&amp;author=K+Patterson&amp;author=MJ+Fritzler&amp;volume=12&amp;publication_year=2013&amp;pages=340-54&amp;pmid=22743034&amp;doi=10.1016/j.autrev.2012.05.011&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Fertig N, Domsic RT, Rodriguez-Reyna T, Kuwana M, Lucas M, Medsger TA, et al.  Anti&#x02013;U11/U12 RNP antibodies in systemic sclerosis: A new serologic marker associated with pulmonary fibrosis. <span><span class="ref-journal">Arthritis Care Res. </span>2009;<span class="ref-vol">61</span>:958–65. doi: 10.1002/art.24586.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC2739404/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/19565553" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fart.24586" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Care+Res&amp;title=Anti&#x02013;U11/U12+RNP+antibodies+in+systemic+sclerosis:+A+new+serologic+marker+associated+with+pulmonary+fibrosis&amp;author=N+Fertig&amp;author=RT+Domsic&amp;author=T+Rodriguez-Reyna&amp;author=M+Kuwana&amp;author=M+Lucas&amp;volume=61&amp;publication_year=2009&amp;pages=958-65&amp;doi=10.1002/art.24586&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, Wigley FM, et al.  Association of the autoimmune disease scleroderma with an immunologic response to cancer. <span><span class="ref-journal">Science. </span>2014;<span class="ref-vol">343</span>:152–7. doi: 10.1126/science.1246886.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC4038033/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/24310608" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1246886" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Association+of+the+autoimmune+disease+scleroderma+with+an+immunologic+response+to+cancer&amp;author=CG+Joseph&amp;author=E+Darrah&amp;author=AA+Shah&amp;author=AD+Skora&amp;author=LA+Casciola-Rosen&amp;volume=343&amp;publication_year=2014&amp;pages=152-7&amp;pmid=24310608&amp;doi=10.1126/science.1246886&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, et al.  Autoantigen microarrays for multiplex characterization of autoantibody responses. <span><span class="ref-journal">Nat Med. </span>2002;<span class="ref-vol">8</span>:295–301. doi: 10.1038/nm0302-295.</span> [<a href="http://europepmc.org/abstract/MED/11875502" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnm0302-295" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Med&amp;title=Autoantigen+microarrays+for+multiplex+characterization+of+autoantibody+responses&amp;author=WH+Robinson&amp;author=C+DiGennaro&amp;author=W+Hueber&amp;author=BB+Haab&amp;author=M+Kamachi&amp;volume=8&amp;publication_year=2002&amp;pages=295-301&amp;pmid=11875502&amp;doi=10.1038/nm0302-295&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Yore MM, Kettenbach AN, Sporn MB, Gerber SA, Liby KT. Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR. <span><span class="ref-journal">PLoS ONE. </span>2011;<span class="ref-vol">6</span>:e22862. doi: 10.1371/journal.pone.0022862.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC3144948/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/21818401" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.pone.0022862" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Proteomic+analysis+shows+synthetic+oleanane+triterpenoid+binds+to+mTOR&amp;author=MM+Yore&amp;author=AN+Kettenbach&amp;author=MB+Sporn&amp;author=SA+Gerber&amp;author=KT+Liby&amp;volume=6&amp;publication_year=2011&amp;pages=e22862&amp;pmid=21818401&amp;doi=10.1371/journal.pone.0022862&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Eng JK, Jahan TA, Hoopmann MR. Comet: An open-source MS/MS sequence database search tool. <span><span class="ref-journal">Proteomics. </span>2013;<span class="ref-vol">13</span>:22–4. doi: 10.1002/pmic.201200439.</span> [<a href="http://europepmc.org/abstract/MED/23148064" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fpmic.201200439" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proteomics&amp;title=Comet:+An+open-source+MS/MS+sequence+database+search+tool&amp;author=JK+Eng&amp;author=TA+Jahan&amp;author=MR+Hoopmann&amp;volume=13&amp;publication_year=2013&amp;pages=22-4&amp;pmid=23148064&amp;doi=10.1002/pmic.201200439&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Hsieh EJ, Hoopmann MR, MacLean B, MacCoss MJ. Comparison of database search strategies for high precursor mass accuracy MS/MS data. <span><span class="ref-journal">J Proteome Res. </span>2009;<span class="ref-vol">9</span>:1138–43. doi: 10.1021/pr900816a.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC2818881/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/19938873" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1021%2Fpr900816a" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Proteome+Res&amp;title=Comparison+of+database+search+strategies+for+high+precursor+mass+accuracy+MS/MS+data&amp;author=EJ+Hsieh&amp;author=MR+Hoopmann&amp;author=B+MacLean&amp;author=MJ+MacCoss&amp;volume=9&amp;publication_year=2009&amp;pages=1138-43&amp;pmid=19938873&amp;doi=10.1021/pr900816a&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. <span><span class="ref-journal">Nat Methods. </span>2007;<span class="ref-vol">4</span>:207–14. doi: 10.1038/nmeth1019.</span> [<a href="http://europepmc.org/abstract/MED/17327847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnmeth1019" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Methods&amp;title=Target-decoy+search+strategy+for+increased+confidence+in+large-scale+protein+identifications+by+mass+spectrometry&amp;author=JE+Elias&amp;author=SP+Gygi&amp;volume=4&amp;publication_year=2007&amp;pages=207-14&amp;pmid=17327847&amp;doi=10.1038/nmeth1019&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="mixed-citation">Oliveros JC. VENNY. An interactive tool for comparing lists with Venn Diagrams. 2007.</span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Greene CS, Krishnan A, Wong AK, Ricciotti E, Zelaya RA, Himmelstein DS, et al.  Zaslavsky E. Understanding multicellular function and disease with human tissue-specific networks. <span><span class="ref-journal">Nat Genet. </span>2015;<span class="ref-vol">47</span>:569–76. doi: 10.1038/ng.3259.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC4828725/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/25915600" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fng.3259" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Zaslavsky+E.+Understanding+multicellular+function+and+disease+with+human+tissue-specific+networks&amp;author=CS+Greene&amp;author=A+Krishnan&amp;author=AK+Wong&amp;author=E+Ricciotti&amp;author=RA+Zelaya&amp;volume=47&amp;publication_year=2015&amp;pages=569-76&amp;pmid=25915600&amp;doi=10.1038/ng.3259&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. <span><span class="ref-journal">Genome Res. </span>2003;<span class="ref-vol">13</span>:2498–504. doi: 10.1101/gr.1239303.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC403769/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/14597658" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1101%2Fgr.1239303" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Cytoscape:+a+software+environment+for+integrated+models+of+biomolecular+interaction+networks&amp;author=P+Shannon&amp;author=A+Markiel&amp;author=O+Ozier&amp;author=NS+Baliga&amp;author=JT+Wang&amp;volume=13&amp;publication_year=2003&amp;pages=2498-504&amp;pmid=14597658&amp;doi=10.1101/gr.1239303&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Reimand J, Arak T, Vilo J. g: Profiler&#x02014;a web server for functional interpretation of gene lists (2011 update) <span><span class="ref-journal">Nucleic Acids Res. </span>2011;<span class="ref-vol">39</span>:W307–15. doi: 10.1093/nar/gkr378.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC3125778/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/21646343" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fnar%2Fgkr378" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=g:+Profiler&#x02014;a+web+server+for+functional+interpretation+of+gene+lists+(2011+update)&amp;author=J+Reimand&amp;author=T+Arak&amp;author=J+Vilo&amp;volume=39&amp;publication_year=2011&amp;pages=W307-15&amp;pmid=21646343&amp;doi=10.1093/nar/gkr378&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. <span><span class="ref-journal">PNAS. </span>1998;<span class="ref-vol">95</span>:14863–8. doi: 10.1073/pnas.95.25.14863.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC24541/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/9843981" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.95.25.14863" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PNAS&amp;title=Cluster+analysis+and+display+of+genome-wide+expression+patterns&amp;author=MB+Eisen&amp;author=PT+Spellman&amp;author=PO+Brown&amp;author=D+Botstein&amp;volume=95&amp;publication_year=1998&amp;pages=14863-8&amp;pmid=9843981&amp;doi=10.1073/pnas.95.25.14863&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Saldanha AJ. Java Treeview&#x02014;extensible visualization of microarray data. <span><span class="ref-journal">Bioinformatics. </span>2004;<span class="ref-vol">20</span>:3246–8. doi: 10.1093/bioinformatics/bth349.</span> [<a href="http://europepmc.org/abstract/MED/15180930" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fbioinformatics%2Fbth349" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Java+Treeview&#x02014;extensible+visualization+of+microarray+data&amp;author=AJ+Saldanha&amp;volume=20&amp;publication_year=2004&amp;pages=3246-8&amp;pmid=15180930&amp;doi=10.1093/bioinformatics/bth349&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="mixed-citation">Novoradovskaya N, Perou C, Whitfield M, Basehore S, Pesich R, Aprelikova O, et al.: Universal human, mouse and rat reference RNA as standards for microarray experiments. In: Mol Bio Cell: 2002: Amer Soc Cell Biology 8120 Woodmont Ave, STE 750, Bethesda, MD 20814-2755 USA; 2002: 241A-241A.</span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Kaji K, Fertig N, Medsger TA, Satoh T, Hoshino K, Hamaguchi Y, et al.  Autoantibodies to RuvBL1 and RuvBL2: A novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. <span><span class="ref-journal">Arthr Care Res. </span>2014;<span class="ref-vol">66</span>:575–84. doi: 10.1002/acr.22163.</span> [<a href="http://europepmc.org/abstract/MED/24023044" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Facr.22163" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthr+Care+Res.&amp;title=Autoantibodies+to+RuvBL1+and+RuvBL2:+A+novel+systemic+sclerosis-related+antibody+associated+with+diffuse+cutaneous+and+skeletal+muscle+involvement&amp;author=K+Kaji&amp;author=N+Fertig&amp;author=TA+Medsger&amp;author=T+Satoh&amp;author=K+Hoshino&amp;volume=66&amp;publication_year=2014&amp;pages=575-84&amp;doi=10.1002/acr.22163&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, et al.  Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome. <span><span class="ref-journal">PLoS ONE. </span>2013;<span class="ref-vol">8</span>:e60442. doi: 10.1371/journal.pone.0060442.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC3616126/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/23573256" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.pone.0060442" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Common+and+Distinct+Clinical+Features+in+Adult+Patients+with+Anti-Aminoacyl-tRNA+Synthetase+Antibodies:+Heterogeneity+within+the+Syndrome&amp;author=Y+Hamaguchi&amp;author=M+Fujimoto&amp;author=T+Matsushita&amp;author=K+Kaji&amp;author=K+Komura&amp;volume=8&amp;publication_year=2013&amp;pages=e60442&amp;pmid=23573256&amp;doi=10.1371/journal.pone.0060442&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Fujimoto M, Shimozuma M, Yazawa N, Kubo M, Ihn H, Sato S, et al.  Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis. <span><span class="ref-journal">Ann Rheum Dis. </span>1997;<span class="ref-vol">56</span>:667–70. doi: 10.1136/ard.56.11.667.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC1752295/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/9462169" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fard.56.11.667" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Rheum+Dis&amp;title=Prevalence+and+clinical+relevance+of+52-kDa+and+60-kDa+Ro/SS-A+autoantibodies+in+Japanese+patients+with+systemic+sclerosis&amp;author=M+Fujimoto&amp;author=M+Shimozuma&amp;author=N+Yazawa&amp;author=M+Kubo&amp;author=H+Ihn&amp;volume=56&amp;publication_year=1997&amp;pages=667-70&amp;pmid=9462169&amp;doi=10.1136/ard.56.11.667&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Ulanet DB, Wigley FM, Gelber AC, Rosen A. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. <span><span class="ref-journal">Arth Care Res. </span>2003;<span class="ref-vol">49</span>:85–92. doi: 10.1002/art.10914.</span> [<a href="http://europepmc.org/abstract/MED/12579598" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fart.10914" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arth+Care+Res&amp;title=Autoantibodies+against+B23,+a+nucleolar+phosphoprotein,+occur+in+scleroderma+and+are+associated+with+pulmonary+hypertension&amp;author=DB+Ulanet&amp;author=FM+Wigley&amp;author=AC+Gelber&amp;author=A+Rosen&amp;volume=49&amp;publication_year=2003&amp;pages=85-92&amp;doi=10.1002/art.10914&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Brouwer R, Vree Egberts WTM, Hengstman GJD, Raijmakers R, van Engelen BGM, Peter Seelig H, et al.  Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. <span><span class="ref-journal">Arth Res. </span>2002;<span class="ref-vol">4</span>:134–8. doi: 10.1186/ar389.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC83843/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/11879549" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2Far389" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arth+Res&amp;title=Autoantibodies+directed+to+novel+components+of+the+PM/Scl+complex,+the+human+exosome&amp;author=R+Brouwer&amp;author=WTM+Vree+Egberts&amp;author=GJD+Hengstman&amp;author=R+Raijmakers&amp;author=BGM+van+Engelen&amp;volume=4&amp;publication_year=2002&amp;pages=134-8&amp;pmid=11879549&amp;doi=10.1186/ar389&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Lega J-C, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, et al.  The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome. <span><span class="ref-journal">Autoimmun Rev. </span>2014;<span class="ref-vol">13</span>:883–91. doi: 10.1016/j.autrev.2014.03.004.</span> [<a href="http://europepmc.org/abstract/MED/24704867" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.autrev.2014.03.004" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmun+Rev&amp;title=The+clinical+phenotype+associated+with+myositis-specific+and+associated+autoantibodies:+A+meta-analysis+revisiting+the+so-called+antisynthetase+syndrome&amp;author=J-C+Lega&amp;author=N+Fabien&amp;author=Q+Reynaud&amp;author=I+Durieu&amp;author=S+Durupt&amp;volume=13&amp;publication_year=2014&amp;pages=883-91&amp;pmid=24704867&amp;doi=10.1016/j.autrev.2014.03.004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Kedersha N, Ivanov P, Anderson P. Stress granules and cell signaling: more than just a passing phase? <span><span class="ref-journal">Trends Biochem Sci. </span>2013;<span class="ref-vol">38</span>:494–506. doi: 10.1016/j.tibs.2013.07.004.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC3832949/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/24029419" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.tibs.2013.07.004" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Biochem+Sci&amp;title=Stress+granules+and+cell+signaling:+more+than+just+a+passing+phase?&amp;author=N+Kedersha&amp;author=P+Ivanov&amp;author=P+Anderson&amp;volume=38&amp;publication_year=2013&amp;pages=494-506&amp;pmid=24029419&amp;doi=10.1016/j.tibs.2013.07.004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Kedersha N, Anderson P. Regulation of translation by stress granules and processing bodies. <span><span class="ref-journal">Prog Mol Biol Transl Sci. </span>2009;<span class="ref-vol">90</span>:155–185. doi: 10.1016/S1877-1173(09)90004-7.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC7102815/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/20374741" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1877-1173(09)90004-7" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prog+Mol+Biol+Transl+Sci.&amp;title=Regulation+of+translation+by+stress+granules+and+processing+bodies&amp;author=N+Kedersha&amp;author=P+Anderson&amp;volume=90&amp;publication_year=2009&amp;pages=155-185&amp;pmid=20374741&amp;doi=10.1016/S1877-1173(09)90004-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Anderson P, Kedersha N. Stress granules: the Tao of RNA triage. <span><span class="ref-journal">Trends Biochem Sci. </span>2008;<span class="ref-vol">33</span>:141–50. doi: 10.1016/j.tibs.2007.12.003.</span> [<a href="http://europepmc.org/abstract/MED/18291657" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.tibs.2007.12.003" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Biochem+Sci&amp;title=Stress+granules:+the+Tao+of+RNA+triage&amp;author=P+Anderson&amp;author=N+Kedersha&amp;volume=33&amp;publication_year=2008&amp;pages=141-50&amp;pmid=18291657&amp;doi=10.1016/j.tibs.2007.12.003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. <span><span class="ref-journal">Annu Rev Pathol-Mech. </span>2011;<span class="ref-vol">6</span>:509–37. doi: 10.1146/annurev-pathol-011110-130312.</span> [<a href="http://europepmc.org/abstract/MED/21090968" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1146%2Fannurev-pathol-011110-130312" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Pathol-Mech.&amp;title=The+pathogenesis+of+systemic+sclerosis&amp;author=TR+Katsumoto&amp;author=ML+Whitfield&amp;author=MK+Connolly&amp;volume=6&amp;publication_year=2011&amp;pages=509-37&amp;doi=10.1146/annurev-pathol-011110-130312&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Op De Be&#x000e9;ck K, Vermeersch P, Verschueren P, Westhovens R, Mari&#x000eb;n G, Blockmans D, et al.  Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. <span><span class="ref-journal">Autoimmun Rev. </span>2012;<span class="ref-vol">12</span>:137–43. doi: 10.1016/j.autrev.2012.02.013.</span> [<a href="http://europepmc.org/abstract/MED/22387973" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.autrev.2012.02.013" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmun+Rev&amp;title=Antinuclear+antibody+detection+by+automated+multiplex+immunoassay+in+untreated+patients+at+the+time+of+diagnosis&amp;author=K+Op+De+Be&#x000e9;ck&amp;author=P+Vermeersch&amp;author=P+Verschueren&amp;author=R+Westhovens&amp;author=G+Mari&#x000eb;n&amp;volume=12&amp;publication_year=2012&amp;pages=137-43&amp;pmid=22387973&amp;doi=10.1016/j.autrev.2012.02.013&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Chung L, Utz P. Antibodies in scleroderma: Direct pathogenicity and phenotypic associations. <span><span class="ref-journal">Curr Rheumatol Rep. </span>2004;<span class="ref-vol">6</span>:156–63. doi: 10.1007/s11926-004-0061-9.</span> [<a href="http://europepmc.org/abstract/MED/15016347" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs11926-004-0061-9" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Rheumatol+Rep&amp;title=Antibodies+in+scleroderma:+Direct+pathogenicity+and+phenotypic+associations&amp;author=L+Chung&amp;author=P+Utz&amp;volume=6&amp;publication_year=2004&amp;pages=156-63&amp;pmid=15016347&amp;doi=10.1007/s11926-004-0061-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="mixed-citation">Anderson P, Kedersha N, Ivanov P. Stress granules, P-bodies and cancer. Biochim Biophys Acta. 2015, 1849, 861&#x02013;870. <span class="nowrap">[<a class="int-reflink" href="/articles/PMC4457708/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/25482014" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Blanco FF, Sanduja S, Deane NG, Blackshear PJ, Dixon DA. Transforming growth factor &#x003b2; regulates P-body formation through induction of the mRNA decay factor tristetraprolin. <span><span class="ref-journal">Mol Cell Bio. </span>2014;<span class="ref-vol">34</span>:180–95. doi: 10.1128/MCB.01020-13.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC3911289/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/24190969" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FMCB.01020-13" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Bio&amp;title=Transforming+growth+factor+&#x003b2;+regulates+P-body+formation+through+induction+of+the+mRNA+decay+factor+tristetraprolin&amp;author=FF+Blanco&amp;author=S+Sanduja&amp;author=NG+Deane&amp;author=PJ+Blackshear&amp;author=DA+Dixon&amp;volume=34&amp;publication_year=2014&amp;pages=180-95&amp;pmid=24190969&amp;doi=10.1128/MCB.01020-13&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Liu J-L, Gall JG. U bodies are cytoplasmic structures that contain uridine-rich small nuclear ribonucleoproteins and associate with P bodies. <span><span class="ref-journal">PNAS. </span>2007;<span class="ref-vol">104</span>:11655–9. doi: 10.1073/pnas.0704977104.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC1899408/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/17595295" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0704977104" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PNAS&amp;title=U+bodies+are+cytoplasmic+structures+that+contain+uridine-rich+small+nuclear+ribonucleoproteins+and+associate+with+P+bodies&amp;author=J-L+Liu&amp;author=JG+Gall&amp;volume=104&amp;publication_year=2007&amp;pages=11655-9&amp;pmid=17595295&amp;doi=10.1073/pnas.0704977104&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Bhanji RA, Eystathioy T, Chan EKL, Bloch DB, Fritzler MJ. Clinical and serological features of patients with autoantibodies to GW/P bodies. <span><span class="ref-journal">Clin Immunol. </span>2007;<span class="ref-vol">125</span>:247–56. doi: 10.1016/j.clim.2007.07.016.</span> <span class="nowrap">[<a class="int-reflink" href="/articles/PMC2147044/">PMC free article</a>]</span> [<a href="http://europepmc.org/abstract/MED/17870671" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.clim.2007.07.016" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Immunol&amp;title=Clinical+and+serological+features+of+patients+with+autoantibodies+to+GW/P+bodies&amp;author=RA+Bhanji&amp;author=T+Eystathioy&amp;author=EKL+Chan&amp;author=DB+Bloch&amp;author=MJ+Fritzler&amp;volume=125&amp;publication_year=2007&amp;pages=247-56&amp;pmid=17870671&amp;doi=10.1016/j.clim.2007.07.016&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Dib H, Tamby MC, Bussone G, Regent A, Berezn&#x000e9; A, Lafine C, Broussard C, Simonneau G, Guillevin L, Witko-Sarsat V, et al.  Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. <span><span class="ref-journal">Eur Respir J. </span>2012;<span class="ref-vol">39</span>(6):1405–1414. doi: 10.1183/09031936.00181410.</span> [<a href="http://europepmc.org/abstract/MED/22005913" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1183%2F09031936.00181410" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&amp;title=Targets+of+anti-endothelial+cell+antibodies+in+pulmonary+hypertension+and+scleroderma&amp;author=H+Dib&amp;author=MC+Tamby&amp;author=G+Bussone&amp;author=A+Regent&amp;author=A+Berezn&#x000e9;&amp;volume=39&amp;issue=6&amp;publication_year=2012&amp;pages=1405-1414&amp;pmid=22005913&amp;doi=10.1183/09031936.00181410&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Naniwa T, Sugiura Y, Banno S, Yoshinouchi T, Matsumoto Y, Ueda R. Ribosomal P protein P0 as a candidate for the target antigen of anti-endothelial cell antibodies in mixed connective tissue. <span><span class="ref-journal">Clin Exp Rheumatol. </span>2007;<span class="ref-vol">25</span>:593–598.</span> [<a href="http://europepmc.org/abstract/MED/17888216" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Rheumatol.&amp;title=Ribosomal+P+protein+P0+as+a+candidate+for+the+target+antigen+of+anti-endothelial+cell+antibodies+in+mixed+connective+tissue&amp;author=T+Naniwa&amp;author=Y+Sugiura&amp;author=S+Banno&amp;author=T+Yoshinouchi&amp;author=Y+Matsumoto&amp;volume=25&amp;publication_year=2007&amp;pages=593-598&amp;pmid=17888216&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Terrier B, Tamby MC, Camoin L, Guilpain P, Broussard C, Bussone G, et al.  Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. <span><span class="ref-journal">Am J Resp Crit Care Med. </span>2008;<span class="ref-vol">177</span>(10):1128–1134. doi: 10.1164/rccm.200707-1015OC.</span> [<a href="http://europepmc.org/abstract/MED/18276943" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200707-1015OC" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Resp+Crit+Care+Med&amp;title=Identification+of+target+antigens+of+antifibroblast+antibodies+in+pulmonary+arterial+hypertension&amp;author=B+Terrier&amp;author=MC+Tamby&amp;author=L+Camoin&amp;author=P+Guilpain&amp;author=C+Broussard&amp;volume=177&amp;issue=10&amp;publication_year=2008&amp;pages=1128-1134&amp;pmid=18276943&amp;doi=10.1164/rccm.200707-1015OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="mixed-citation">Terrier B, Tamby MC, Camoin L, Guilpain P, B&#x000e9;r&#x000e9;zn&#x000e9; A, Tamas N, et al. Anti-fibroblast antibodies from systemic sclerosis patients bind to &#x003b1;-enolase and are associated with interstitial lung disease. Ann Rheum Dis. 2009. [<a href="http://europepmc.org/abstract/MED/19293162" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="mixed-citation">Satoh M, Chan JY, Ceribelli A, del-Mercado MV, Chan EK. Autoantibodies to Argonaute 2 (Su antigen). In: Ten Years of Progress in GW/P Body Research. Springer. 2013:45-59.</span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Siapka S, Patrinou-Georgoula M, Vlachoyiannopoulos PG, Guialis A. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen. <span><span class="ref-journal">Autoimmunity. </span>2007;<span class="ref-vol">40</span>(3):223–233. doi: 10.1080/08916930701352357.</span> [<a href="http://europepmc.org/abstract/MED/17453722" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1080%2F08916930701352357" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmunity&amp;title=Multiple+specificities+of+autoantibodies+against+hnRNP+A/B+proteins+in+systemic+rheumatic+diseases+and+hnRNP+L+as+an+associated+novel+autoantigen&amp;author=S+Siapka&amp;author=M+Patrinou-Georgoula&amp;author=PG+Vlachoyiannopoulos&amp;author=A+Guialis&amp;volume=40&amp;issue=3&amp;publication_year=2007&amp;pages=223-233&amp;pmid=17453722&amp;doi=10.1080/08916930701352357&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Kubo M, Ihn H, Kuwana M, Asano Y, Tamaki T, Yamane K, Tamaki K. Anti-U5 snRNP antibody as a possible serological marker for scleroderma&#x02013;polymyositis overlap. <span><span class="ref-journal">Rheumatol. </span>2002;<span class="ref-vol">41</span>(5):531–534. doi: 10.1093/rheumatology/41.5.531.</span> [<a href="http://europepmc.org/abstract/MED/12011376" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Frheumatology%2F41.5.531" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatol&amp;title=Anti-U5+snRNP+antibody+as+a+possible+serological+marker+for+scleroderma&#x02013;polymyositis+overlap&amp;author=M+Kubo&amp;author=H+Ihn&amp;author=M+Kuwana&amp;author=Y+Asano&amp;author=T+Tamaki&amp;volume=41&amp;issue=5&amp;publication_year=2002&amp;pages=531-534&amp;doi=10.1093/rheumatology/41.5.531&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="mixed-citation">Hashish L, Trieu E, Sadanandan P, Targoff I. Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with anti-synthetase syndrome. In: Arthritis Rheum. 2005; 2005: S312-S312</span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. <span><span class="ref-journal">Rheumatol. </span>2007;<span class="ref-vol">46</span>(6):1005–1008. doi: 10.1093/rheumatology/kem045.</span> [<a href="http://europepmc.org/abstract/MED/17392287" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Frheumatology%2Fkem045" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatol&amp;title=Anti-synthetase+syndrome:+a+new+autoantibody+to+phenylalanyl+transfer+RNA+synthetase+(anti-Zo)+associated+with+polymyositis+and+interstitial+pneumonia&amp;author=Z+Betteridge&amp;author=H+Gunawardena&amp;author=J+North&amp;author=J+Slinn&amp;author=N+McHugh&amp;volume=46&amp;issue=6&amp;publication_year=2007&amp;pages=1005-1008&amp;doi=10.1093/rheumatology/kem045&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Mimori T. Autoantibodies in Connective Tissue Diseases. Clinical Significance and Analysis of Target Autoantigens. <span><span class="ref-journal">Internal Med. </span>1999;<span class="ref-vol">38</span>(7):523–532. doi: 10.2169/internalmedicine.38.523.</span> [<a href="http://europepmc.org/abstract/MED/10435356" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2169%2Finternalmedicine.38.523" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Internal+Med&amp;title=Autoantibodies+in+Connective+Tissue+Diseases.+Clinical+Significance+and+Analysis+of+Target+Autoantigens&amp;author=T+Mimori&amp;volume=38&amp;issue=7&amp;publication_year=1999&amp;pages=523-532&amp;pmid=10435356&amp;doi=10.2169/internalmedicine.38.523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Svegliati BS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, et al.  Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">354</span>(25):2667–2676. doi: 10.1056/NEJMoa052955.</span> [<a href="http://europepmc.org/abstract/MED/16790699" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa052955" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Stimulatory+autoantibodies+to+the+PDGF+receptor+in+systemic+sclerosis&amp;author=BS+Svegliati&amp;author=M+Santillo&amp;author=F+Bevilacqua&amp;author=M+Luchetti&amp;author=T+Spadoni&amp;volume=354&amp;issue=25&amp;publication_year=2006&amp;pages=2667-2676&amp;pmid=16790699&amp;doi=10.1056/NEJMoa052955&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3705194&amp;issue-id=168031&amp;journal-id=349&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Arthritis Research &#x0026; Therapy</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>

<script type="text/javascript">
$(document).ready(function(){
   $('A.cite-reflink[rid]').mouseover(function(){ TagToTipAllowed($(this).attr('rid'), WIDTH, 300, FIX, [this, 0, 0], ABOVE, true); });
   $('A.cite-reflink[rid]').mouseout(function() { UnTipAllowed(); });
});
</script>


</div>
<div style="text-align:center">

</div>
</div>
</div>
<div class="ui-tabs-panel ui-tabs-hide" id="fragment-related-citations">
<div id="idc">
<span id="references_loading_label"><img src="/images/ajax-loader.gif" style="width:25px" alt="Loading"></span>
<div class="citations_right" style="display:none"><small><a href="/Help#citationsnetwork">&#160;<img alt="" src="/images/qmark.png"/>How does Europe PMC derive its citations network?</a></small></div>
<div class="citations" >
<h3>

<span style="display:none">
<span class="abs_relcitation_count">

&#160;
&#8226;
<a href="" target="_blank">
Web of Science&#174; times cited (<span></span>)</a>- subscription required

</span>
</span>
</h3>

<div class="citedByHolder collapsed" style="display:none">
<div class="citations_listing">

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
<br />
<br />
<div class="citations">


<div class="citesFollowingHolder collapsed" style="display:none">
<div class="citations_listing">

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>
</div>
<div class="ui-tabs-panel ui-tabs-hide" id="fragment-related-pubmedarts">
<div id="idd">
<span id="rel_articles_loading_label"><img src="/images/ajax-loader.gif" style="width:25px" alt="Loading"></span>
<div id="related_reviews_id">
<div class="citations">
<h3></h3>
<div class="citationsHolder collapsed" style="display:none">
<div class="citations_listing">

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>
<br/>
<div id="other_related_articles_id">
<div class="citations">
<h3></h3>
<div class="citationsHolder collapsed" style="display:none">
<div class="citations_listing">

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>
<br>
<div class="related-articles-citepeer hidden">
<h3 class="citepeer-title">CitePeer Related Articles</h3>
<img src="/images/CitePeer-logo.png" alt="" class="citepeer-logo float-left">
<a href="http://citepeer.io/#/?pubmedId=26801089" class="citepeer-link" target="_blank">http://citepeer.io/#/?pubmedId=26801089</a>
</div>
</div>
</div>
<div class="ui-tabs-panel ui-tabs-hide" id="fragment-related-dataLinks">
<div id="ide">
<span id="loading_dataLinks_label" style="margin-top:10px"><img src="/images/ajax-loader.gif" style="width:25px" alt="Loading"></span>

<div style="display:block;">

<div class="data_list_div">



</div>
</div>


<div style="display:block;">

<div class="data_list_div">



</div>
</div>

<script type="text/javascript">
/*<![CDATA[*/

if($(".data_list_div").find("a").length==0){
$(".data_list_div").hide();
$("#data_title").hide();
}

/*]]>*/
</script>
<script type="text/javascript">
/*<![CDATA[*/

function toggleVis(el){
el.getElementsByTagName("i")[0].classList.toggle("fa-caret-right");
el.getElementsByTagName("i")[0].classList.toggle("fa-caret-down");
var IdContainer = $(el).parent().attr("id");
$("#"+IdContainer+" .section_data_link").each(function(index, el){
$(el).toggleClass("data_list_hidden");
});
}

/*]]>*/
</script>
</div>
</div>
<div class="ui-tabs-panel ui-tabs-hide" id="fragment-related-bioentities">
<div id="idf">
<span id="loading_bioentities_label"><img src="/images/ajax-loader.gif" alt="Loading" style="width:25px"></span>

<div id="protiensHolder" class="collapsed">
<div id="proteins" style="display:none;">
<h3>Genes &amp; Proteins</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="protiensintHolder" class="collapsed">
<div id="protiensint" style="display:none;">
<h3>Protein Interactions</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="protienssqnHolder" class="collapsed">
<div id="protienssqn" style="display:none;">
<h3>Protein Families</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="nuclesqnHolder" class="collapsed">
<div id="nuclesqn" style="display:none;">
<h3>Nucleotide Sequences</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="array_expressHolder" class="collapsed">
<div id="array_express" style="display:none;">
<h3>Functional Genomics Experiments</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="protiensstructHolder" class="collapsed">
<div id="protiensstruct" style="display:none;">
<h3>Protein Structures</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="gotermsHolder" class="collapsed">
<div id="goterms" style="display:none;">
<h3>Gene Ontology (GO) Terms</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="organismsHolder" class="collapsed">
<div id="organisms" style="display:none;">
<h3>Species</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="diseasesHolder" class="collapsed">
<div id="diseases" style="display:none;">
<h3>Diseases</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="accessionHolder" class="collapsed">
<div id="accession" style="display:none;">
<h3>Data Citations</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="chemicalHolder" class="collapsed">
<div id="chemical" style="display:none;">
<h3>Chemicals</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="efoHolder" class="collapsed">
<div id="efo" style="display:none;">
<h3>Experimental Factor Ontology (EFO) Terms</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>


<div id="prideHolder" class="collapsed">
<div id="pride" style="display:none;">
<h3>Proteomics Data</h3>


<div class="btmsmr collapsed" style="display:none;">

<div class="relartsdiv">

<div class="tmsummary">
<div class="text1">
<div style="width:100%">

</div>
</div>
</div>

</div>
<div class="showHideRelated">
<a>Show all items</a>
</div>
</div>
</div>
</div>

</div>
</div>
<div class="ui-tabs-panel ui-tabs-hide" id="fragment-related-labLinks">
<div id="id10" style="display:block;">
<span id="loading_links_label"><img src="/images/ajax-loader.gif" style="width:25px" alt="Loading"></span>



</div>
</div>
</div>
</div>
</div>
<div id="page_info_marginFulltext" class="page_info_margin">

<div>
<div style="display:none">

</div>
<div>
<script type="text/javascript">$(document).ready(function(){
 document.getElementById("fulltextnavpanel").className='citation_navigation_selected';
 });</script>
<div id="movetotop">
<div class="vertmenu formats">
<h2>Menu</h2>
<div class="list_article_link">

<div class="citation_navigation_unselected" style="display:none">
<a href="../../../article/MED/26801089" tabindex="1" itemprop="mainEntityOfPage">Abstract</a>
</div>

<div id="fulltextnavpanel" class="citation_navigation_unselected full" style="display:none">
Full Text <img border="0" src="/images/small_logo.gif" style="height:14px;width:14px" alt=""/>
</div>


<div class="formatMenuTitle">
<div id="downloadHeading">
<div><i class="fa fa-download" style="color: #347DC5; font-size:1.2em"></i></div>
<div style="border-bottom: 5px solid #B4CADA;">Download</div>
</div>
</div>
<div class="citation_navigation_unselected" style="border:none">
<a href="../../pmc4724133?pdf=render" itemprop="mainEntityOfPage" tabindex="2" target="_blank" style="text-decoration: none;">PDF</a>
</div>

</div>
</div>
</div>
<div class="vertmenu">

</div>
</div>
</div>


<div id="id4"><div><img alt="Loading..." src="../../../wicket/resource/org.apache.wicket.ajax.AbstractDefaultAjaxBehavior/indicator-ver-03CE3DCC84AF110E9DA8699A841E5200.gif"/></div></div>
<div id="annotation_legend_container"></div>
</div>

<span>
<script type="text/javascript">
/*<![CDATA[*/

function getXMLHttpRequestObject()
{
var xmlhttp;
if (!xmlhttp && typeof XMLHttpRequest != 'undefined') {
try {
xmlhttp = new XMLHttpRequest();
} catch (e) {
xmlhttp = false;
}
}
return xmlhttp;
}
function getArticleXMLHttpRequestToUrl(url)
{
var http = new getXMLHttpRequestObject();
var abs = "/articles/"
http.open("GET", abs+url, true);
http.onreadystatechange = function() {
}
http.send(null);
}
function getAbstractXMLHttpRequestToUrl(url)
{
var http = new getXMLHttpRequestObject();
var abs = "/abstract/"
http.open("GET", abs+url, true);
http.onreadystatechange = function() {
}
http.send(null);
}
function getXMLHttpRequestForVisualisation(url)
{
var http = new getXMLHttpRequestObject();
http.open("GET",url, true);
http.onreadystatechange = function() {
}
http.send(null);
}

/*]]>*/
</script>
</span>
<script type="text/javascript">$(document).ready(function(){
 jQuery('#tabs_abstract').tabs("disable", 3); 
 });

jQuery('#dataLinksarts').removeClass('ui-tabs-enabled');

jQuery('#dataLinksarts').addClass('ui-tabs-disabled');

</script>
</div>
<script type="text/javascript">
/*<![CDATA[*/

jQuery('#tabs_abstract').tabs();

/*]]>*/
</script>
<script type="text/javascript">goToFullTextAnnotation('pmc4724133','fragment-fulltext', 'annotation_legend_container');</script>
<script type="text/javascript">
/*<![CDATA[*/

jQuery(document).on("scroll", function(e) {
positionLegendAnnotation(true, true, false);
});
positionLegendAnnotation(true, true, false);

/*]]>*/
</script>
<div id="popup_figures"></div>
<script type="text/javascript" src="../../../wicket/resource/uk.bl.ukpmc.web.pages.search.ShowText/ShowText-ver-50439614D1810C21282790808511CE09.js"></script>

</div>
<footer id="epmc_pageFooter"><div class="epmc-elements"><div data-v-66258b64="" id="footer"><div data-v-66258b64="" id="follow-us-section"><p class="h2">Follow us</p><div id="follow-us-icons"><a href="http://blog.europepmc.org/" class="action"><i class="fas fa-blog feature-large"></i><br>News blog
</a><a href="//europepmc.github.io/techblog/" class="action"><i class="fas fa-cogs feature-large"></i><br>Technical blog
</a><a href="//twitter.com/EuropePMC_news" class="action"><i class="fab fa-twitter feature-large"></i><br>Twitter
</a><a href="//www.youtube.com/user/EuropePMC" class="action"><i class="fab fa-youtube feature-large"></i><br>YouTube
</a></div></div><div data-v-66258b64="" id="menus" class="grid-row"><div data-v-66258b64="" class="col-16"><div data-v-66258b64=""><p data-v-66258b64="" class="h5"><a data-v-66258b64="" href="/About" target="[object Object]">About</a></p><div data-v-66258b64=""><a data-v-66258b64="" href="/About" class="extra-small">About Europe PMC</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/Funders" class="extra-small">Funders</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/Joining" class="extra-small">Joining Europe PMC</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/Governance" class="extra-small">Governance</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/Roadmap" class="extra-small">Roadmap</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/Outreach" class="extra-small">Outreach</a></div></div><div data-v-66258b64=""><p data-v-66258b64="" class="h5"><a data-v-66258b64="" href="/tools" target="[object Object]">Tools</a></p><div data-v-66258b64=""><a data-v-66258b64="" href="/tools" class="extra-small">Tools overview</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/orcid/import" class="extra-small">ORCID article claiming</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/journalList" class="extra-small">Journal list</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/grantfinder" class="extra-small">Grant finder</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/LabsLink" class="extra-small">External links service</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/RssFeeds" class="extra-small">RSS feeds</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/Annotations" class="extra-small">Annotations</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/AnnotationsSubmission" class="extra-small">Annotations submission service</a></div></div><div data-v-66258b64=""><p data-v-66258b64="" class="h5"><a data-v-66258b64="" href="/developers" target="[object Object]">Developers</a></p><div data-v-66258b64=""><a data-v-66258b64="" href="/developers" class="extra-small">Developer resources</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/RestfulWebService" class="extra-small">Articles RESTful API</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/GristAPI" class="extra-small">Grants RESTful API</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/API-case-studies" class="extra-small">API case studies</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/SoapWebServices" class="extra-small">SOAP web service</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/AnnotationsApi" class="extra-small">Annotations API</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/OaiService" class="extra-small">OAI service</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/downloads" class="extra-small">Bulk downloads</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="//groups.google.com/a/ebi.ac.uk/forum/#!forum/epmc-webservices" class="extra-small">Developers Forum</a></div></div><div data-v-66258b64=""><p data-v-66258b64="" class="h5"><a data-v-66258b64="" href="/Help" target="[object Object]">Help</a></p><div data-v-66258b64=""><a data-v-66258b64="" href="/Help" class="extra-small">Help using Europe PMC</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/searchsyntax" class="extra-small">Search syntax reference</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="/ContactUs" class="extra-small">Contact us</a></div></div><div data-v-66258b64=""><p data-v-66258b64="" class="h5"><a data-v-66258b64="" href="/ContactUs" target="[object Object]">Contact us</a></p><div data-v-66258b64=""><a data-v-66258b64="" href="/ContactUs" class="extra-small">Helpdesk</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="#" onclick="var w = window.open('/feedback?url='+window.location.origin + window.location.pathname + encodeURIComponent(window.location.search), 'ukpmc_feedback', 'scrollbars=no,location=no,menuBar=yes,resizable=yes,status=no,toolbar=yes,width=600,height=800'); try {if (w.blur) w.focus();}catch(ignore){}; return false;" class="extra-small">Feedback</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="//twitter.com/EuropePMC_news" class="extra-small">Twitter</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="http://blog.europepmc.org/" class="extra-small">Blog</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="//europepmc.github.io/techblog/" class="extra-small">Tech blog</a></div><div data-v-66258b64=""><a data-v-66258b64="" href="//groups.google.com/a/ebi.ac.uk/forum/#!forum/epmc-webservices" class="extra-small">Developer forum</a></div></div></div></div><div data-v-66258b64="" id="feedback"><div data-v-66258b64="" class="grid-row"><div data-v-66258b64="" class="col-16"><span data-v-66258b64="" id="feedback-label">Let us know how we are doing.</span><span data-v-66258b64="" id="mobile-feedback-label">How are we doing.</span><input data-v-66258b64="" id="feedback-button" type="button" value="Give feedback" class="secondary"></div></div></div><div data-v-66258b64="" id="elixir-banner"><div data-v-66258b64="" class="grid-row"><div data-v-66258b64="" class="col-16"><a data-v-66258b64="" href="//www.elixir-europe.org/platforms/data/core-data-resources"><div data-v-66258b64="" id="elixir-logo-kite"></div><p data-v-66258b64="" class="h5">Europe PMC is part of the ELIXIR infrastructure</p><div data-v-66258b64="" id="elixir-logo-text" class="small">
Europe PMC is an ELIXIR Core Data Resource
<span data-v-66258b64="" id="elixir-banner-learn-more">Learn more &gt;</span></div></a></div></div></div><div data-v-66258b64="" id="footer-bottom"><div data-v-66258b64="" class="grid-row"><div data-v-66258b64="" class="col-16 extra-small">
Europe PMC is a service of the
<a data-v-66258b64="" href="/Funders">Europe PMC Funders' Group</a>, in partnership with
the <a data-v-66258b64="" href="//www.ebi.ac.uk/">European Bioinformatics Institute</a>;
and in cooperation with the
<a data-v-66258b64="" href="//www.ncbi.nlm.nih.gov/">
National Center for Biotechnology Information
</a>
at the
<a data-v-66258b64="" href="//www.nlm.nih.gov/">
U.S. National Library of Medicine (NCBI/NLM) </a>. It includes content provided to the
<a data-v-66258b64="" href="//www.ncbi.nlm.nih.gov/pmc/">PMC International archive</a>
by participating publishers.
</div></div><div data-v-66258b64="" id="footer-bottom-links" class="extra-small"><a data-v-66258b64="" href="/ContactUs">Contact us</a>
|
<a data-v-66258b64="" href="/PrivacyNotice">Privacy</a>
|
<a data-v-66258b64="" href="//www.ebi.ac.uk/Information/termsofuse.html">Terms of use</a>
|
<a data-v-66258b64="" href="/Copyright">Copyright</a>
|
<a data-v-66258b64="" href="/Accessibility">Accessibility</a></div></div></div></div></footer>



<script type="text/javascript" src="/Scripts/wz_tooltip.js?v=12087"></script>
<script type="text/javascript">
/*<![CDATA[*/

/**$(document).ready(function(){
$('#container-1 > ul').tabs();
});*/

/*]]>*/
</script>
<script type="text/javascript">
/*<![CDATA[*/

var width = $(window).width();
if (width < 700) {
/* $('#feedback-container').css('top', '44px'); */
/* $('#feedback-container').css('position', 'absolute'); */
$('#feedback-container').draggable();
} else {
//@date 23/08/2016 https://www.ebi.ac.uk/panda/jira/browse/CIT-2216
//$('#feedback-container').css('top', height - 39 + 'px');
//$('#feedback-container').css('position', 'fixed');
}

/*]]>*/
</script>
<style>
/*<![CDATA[*/

@media screen and (max-width: 870px) {
#feedback-container {
top: 44px;
bottom: auto;
position: absolute;
}
}

/*]]>*/
</style>
<script type="text/javascript">
/*<![CDATA[*/

jQuery.cachedScript = function (url, options) {
// Allow user to set any option except for dataType, cache, and url
options = jQuery.extend(options || {}, {
dataType: "script",
cache: true,
url: url
});
// Use $.ajax() since it is more flexible than $.getScript
// Return the jqXHR object so we can chain callbacks
return jQuery.ajax(options);
};
jQuery.cachedCss = function (url, options) {
// Allow user to set any option except for dataType, cache, and url
options = jQuery.extend(options || {}, {
dataType: "text",
cache: true,
url: url
});
// Use $.ajax() since it is more flexible than $.getScript
// Return the jqXHR object so we can chain callbacks
return jQuery.ajax(options);
};

/*]]>*/
</script>
<script type="text/javascript"></script>
<noscript></noscript>
</div>
</body>
</html>
